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DEDICATION 
“'It doesn't happen all at once,' said the Skin Horse. 'You become. It takes a long time. 
That's why it doesn't happen often to people who break easily, or have sharp edges, or 
who have to be carefully kept. Generally, by the time you are Real, most of your hair has 
been loved off, and your eyes drop out and you get loose in the joints and very shabby. 
But these things don't matter at all, because once you are Real you can't be ugly, except 
to people who don't understand.’” –Margery Williams Bianco, The Velveteen Rabbit 
 
I am constantly perplexed, challenged, frustrated, and fascinated with the 
construct of body image. There are moments where I find myself wishing there was 
nothing left to study—that the contouring, coloring, shape, disfigurements, and visible 
differences of the face and body held as much power as, say, the exact specifications of 
one’s spleen in the fostering of human connection and the development of identify, 
confidence, and worth. However, in this line of research, I am reminded that at present, 
such is not our state; the outside world can be judgmental and harsh. But, I am also 
constantly reminded that people can be compassionate, kind, patient, and authentic. This 
project is dedicated to the humans living with rare diseases, especially those conditions 
that change the outer masks and exterior armor that adorn us.  
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Rationale. Systemic Sclerosis (SSc, scleroderma) is a rare and progressive 
rheumatic disease of unknown etiology and heterogeneous presentation that results in 
fibrosis of the skin and internal organs. A common and distressing symptom of SSc is 
disfigurement in visible and socially relevant areas of the body (i.e., face and hands). 
Disease-related changes in appearance have been associated with body image 
dissatisfaction and social anxiety. Although there have been studies identifying correlates
xvii 
 of body image dissatisfaction, there is a need for an examination that considers 
the complex relationships among the personal and social aspects of appearance changes. 
The present study used latent profile analysis (LPA) to identify body image typologies. 
Identified groups were then compared on key sociodemographic, medical, and 
psychosocial variables.  
Design. The sample consisted of 942 patients with physician-confirmed SSc 
enrolled in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort who 
completed study questionnaires from April 2014 through October 2016. Patients in the 
SPIN Cohort were enrolled at 28 centers from Canada, the United States, and the United 
Kingdom. Prior to running the analysis, the sample was randomized into two different 
groups that were treated as independent samples (N = 469 in Sample 1 and N = 473 in 
Sample 2); this randomization was completed to allow for a replication analysis of the 
findings. For the first aim, exploratory LPA was used to derive categorical latent 
variables that signified profiles of similarly scoring individuals using one indicator of 
objective skin involvement, three indicators of subjective body image, and three 
indicators of social anxiety. For the second aim, group differences were examined, using 
the Lanza three-step method for modeling auxiliary variables, for selected 
sociodemographic, medical, and psychosocial variables.  
Results. In both samples, a two-profile solution was derived. These two classes 
were substantively analyzed for patterns of scores and termed the Appearance 
Comfortable (n = 334 and n = 375 in Sample 1 and Sample 2, respectively) and 
Appearance Distressed (n = 135 and n = 98 in Sample 1 and Sample 2, respectively) 
groups. In both samples, younger age, diffuse disease subtype, and the presence of 
 xviii 
hypo/hyper-pigmentation were associated with membership in the Appearance Distressed 
group. Additionally, patients in the Appearance Distressed group had significantly higher 
scores on measures of depressive and anxious symptoms and physical disability.  
Conclusions. The present study was the first to use LPA in the context of body 
image in SSc, and the first study to identify typologies of patients based on indicators of 
body image in any disfiguring condition. Two distinct groups were identified 
distinguishing between an Appearance Comfortable group, comprised of patients with 
lower objective skin involvement, better body image, and lower social anxiety and an 
Appearance Distressed group including patients who had higher objective skin 
involvement, poorer body image, and higher social anxiety. Interestingly, although the 
differences in objective skin involvement were relatively small, the differences in body 
image and social anxiety scores were relatively large. This suggests that the body image 
experience in SSc is driven by psychosocial factors beyond objective appearance. The 
results also elucidated variables that can indicate likely group membership and help 
identify which individuals may be most vulnerable to poorer body image-related 
outcomes.  
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CHAPTER 1: INTRODUCTION 
The present study was the first to utilize the multivariate statistical technique of 
latent profile analysis (LPA) in the context of body image in a rare, rheumatic disease, 
systemic sclerosis (scleroderma, SSc). The use of this methodology enabled the 
exploration of two questions regarding the experience of body image in SSc. First, LPA 
allowed the identification of distinct groups that emerged based on body image and social 
anxiety indicators. Second, once profiles were established, the analysis enabled 
comparison of the groups to determine whether patients in the identified groups differed 
on selected sociodemographic, medical, and psychosocial variables.  
The present study used baseline data for a total of 942 men and women with SSc 
who were enrolled in the Scleroderma Patient-centered Intervention Network (SPIN) 
Cohort (Kwakkenbos et al., 2013) in Canada, the United States, and the United Kingdom 
in order to derive typologies of SSc patients using various body image indicators. The 
total sample was randomized into two different groups that were treated as independent 
samples (N = 469 in Sample 1 and N = 473 in Sample 2) to examine whether the findings 
could be replicated.  
Identifying typologies of patients based on various indicators of body image and 
social anxiety can enable a more refined understanding of the experience of body image 
and associated outcomes in SSc patients. The present study was an attempt to unpack the 
subjective and objective indicators of body image and closely related social impacts in a 
population in which changes in appearance are prevalent and burdensome (Jewett et al., 
2016a; Kwakkenbos et al., 2015a). In so doing, a multi-dimensional, non-linear, 
understanding of body image in SSc can be achieved (Bregman, Malik, Page, Makynen, 
  2 
& Lindahl, 2013). This more refined knowledge of body image in SSc can then identify 
groups at higher risk for poorer outcomes. It is the goal of this researcher that the results 
eventually lead to an improved understanding of the broad construct of body image 
specific to SSc patients to improve overall quality of life and perhaps contribute to 
disease-specific assessment and intervention development in the future. 
Prior to delving into the findings of the present study, a background of the 
relevant literature in body image will be presented, a brief overview of SSc will be 
provided, and the existing research examining body image impacts in SSc will be 
summarized. Gaps in the literature will be highlighted and the role of the present study in 
filling these gaps will be elucidated.  
Chapter 1 is being prepared in part for publication. This publication will be co-
authored by Vanessa L. Malcarne, Scott C. Roesch, Marie-Eve Carrier, Linda 
Kwakkenbos, Sarah D. Mills, Rina S. Fox, and Brett D. Thombs. The dissertation author 
was the primary investigator and author of this material. 
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CHAPTER 2: BACKGROUND AND SIGNIFICANCE 
 
2.1 The Construct of Body Image 
 Body image is a complex construct that is notoriously difficult to empirically 
tether (Banfield & McCabe, 2002). Broadly, body image refers to perceptions, thoughts, 
feelings, and behaviors about one’s body. The seeds of body image research took root via 
neuropsychological research exploring such phenomena as phantom limb and 
hemiasomatognosia over a century ago, and germinated in the late 1960s via 
psychoanalytic explorations of body awareness and the body image boundary (Cash, 
2004; Fisher, 1986). But it is in recent decades that there has been a booming growth of 
body image research, however much of it has been limited to the study of eating disorders 
(Cash, 2004; Grogan, 2006). In fact, Grogan (2006) argued that there are biases in 
definitions of body image (e.g., the inclusion of body shape and size evaluations) and 
populations (e.g., physically healthy girls) shaped by the origins of body image research 
in the fields of clinical psychology and psychiatry.  
Cash (2004) defined the multidimensional construct of body image as follows, 
“Body image refers to the multifaceted psychological experience of embodiment, 
especially but not exclusively one’s physical appearance” (p. 1). Evaluative (e.g., 
perceptions and attitudes) and investment (e.g., salience or cognitive-behavioral-placed 
value) components of body image cohere to create the construct of body image (Cash, 
1994, 2002a, 2002b; Cash, Melnyk, & Hrabosky, 2004a). The evaluative component 
includes appraisals of and satisfaction with appearance whereas the investment 
component includes the value and importance that one affords appearance (Cash, 1994; 
Cash, Fleming, Alindogan, Steadman, & Whitehead, 2002). Furthermore, thoughts, 
  4 
emotions, and behaviors related to one’s body can be a product of one’s overall 
appearance or related to a specific body part or quality, such as weight (Cash, Morrow, 
Hrabosky, & Perry, 2004b). The differentiation between body image dissatisfaction and 
distress is also important to note. Whereas body image dissatisfaction refers to an 
evaluative process, body image distress (or, disturbance) typically also includes more 
strongly negative body image emotions and can point to a more extreme, pathological 
process, for example body dysmorphia in eating disordered populations (Hrabosky et al., 
2009).  
 One of the leading theoretical frameworks in body image research is the 
sociocultural model, which is based on an understanding that 1) there are socially and 
culturally constituted beauty ideals; 2) these ideals are societally transmitted to 
individuals; 3) the ideals are internalized and manifest in [dis]satisfaction within an 
individual depending on the extent to which the individual meets the prescribed ideals. 
This model is most commonly referenced in relation to body weight and shape and 
culturally sanctioned ideals of thinness or beauty (Tiggemann, 2011), and the role of 
media in perpetuating such ideals (Thompson & Heinbert, 1999). The utility of the model 
in terms of highlighting the role of one’s sociocultural context and products in body 
image was demonstrated in a study that showed that exposure to Barbie dolls was 
associated with lower body esteem and thinness desire in young girls (Dittmar, Halliwell, 
& Ive, 2006). Tiggemann (2011) cautioned, however, that the sociocultural model is 
overly simplistic and fails to take into account other (e.g., psychological) influences; if 
the model were sufficient, the great majority of individuals in every society would be 
suffering from elevated body dissatisfaction and eating disorders. 
  5 
Although much of the work in body image has centered around eating disorders, 
there has been an increasing awareness of the construct of body image in other contexts 
as well, including chronic illness and disfigurement (congenital and acquired; Rumsey & 
Harcourt, 2004).  
2.2 Body Image in Disfigurement 
Differentiating disfigurement from physical normality. Rumsey and Harcourt 
(2004) noted a distinction between the types of concerns about appearance that are 
common in the general (i.e., non-disfigured) population and the specific concerns of 
individuals living with visible differences. Of course, the line demarcating disfigurement 
from physical normality is not always clear and there can be disagreement, especially in 
cases involving body dysmorphia, about what is considered physically normal. There is 
an entire evolutionary biology literature devoted to such constructs as fluctuating 
asymmetries facial sexual dimorphism. However, there are numerous health conditions, 
both congenital (e.g., Treacher-Collins’ syndrome) and acquired (e.g., burns) that can 
contribute to visible differences that can be considered deviations from what is physically 
typical in one’s cultural context. Certain visible differences attributed to medical reasons 
are common (e.g., approximately one-third of individuals will be affected by skin 
conditions, such as acne or uticaria, at any given time point; Thompson, 2011), whereas 
other conditions impacting appearance (e.g., ichthyosis vulgaris) can be quite rare. 
Although the heterogeneity in visible disfigurement in terms of such characteristics as 
body areas affected, severity, visibility, and individual characteristics can seem 
“daunting” (p. 85) in a research context, in fact, the body image challenges tend to most 
commonly involve 1) negative perceptions of the self and 2) social difficulties (Rumsey 
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& Harcourt, 2004). In other words, the challenges of living with a visible difference can 
be divided into personal and the social demands.  
 Apropos the multidimensional nature of the construct of body image, the severity 
of disfigurement does not directly predict outcomes such as adjustment (Rumsey, 2002a, 
2002b). Thus, there is not only a distinction between objective severity and subjective 
severity, but also a host of other variables, such as salience and resilience, that may 
impact the relationship between severity of disfigurement and various outcomes. 
Although objective ratings of attractiveness or disfigurement can be challenging to 
empirically acquire, there have been some studies that examined both objective and 
subjective disfigurement. For example, Moss (2005) used both objective (i.e., clinician) 
ratings of severity and subjective (i.e., patient) ratings of severity in order to examine the 
relationship between severity of disfigurement and psychological adjustment.  
 Thompson (2011) described three primary categorizations among psycho-
dermatological conditions: 1) dermatological issues that are grounded in 
psychopathology (e.g., trichotillomania); 2) conditions that are psychophysiological (e.g., 
a subtype of alopecia exacerbated by stress); and 3) medical conditions for which 
psychological impacts are secondary (e.g., depression and anxiety related to systemic 
lupus erythematosus [SLE]). Rheumatologic conditions that cause disfigurement, such as 
scleroderma, would fall into this third category. Jolly (2011) described that body image 
issues are pervasive across rheumatologic diseases, which include visible and non-visible 
adverse bodily changes. Jolly (2011) underscored that the detection and treatment of 
body image dissatisfaction and distress in rheumatologic conditions may improve overall 
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health outcomes and costs associated with the disease because of the role of body image 
distress in other psychosocial outcomes and quality of life.  
Social impacts. The impacts of a visible difference on social processes can be 
devastating and individuals with visible differences have reported social challenges such 
as staring, invasive questions, and rude comments (Rumsey 2002a, 2002b; Rumsey & 
Harcourt, 2004). Visible differences have been referred to as a social disability by 
Macgregor (1979) because of the potential for social impacts and noticeability (Rumsey 
& Harcourt, 2004). Both experimental and observational studies have shown that people 
tend to react negatively in response to individuals with visible skin disfigurements 
(Thompson, 2011). Grandfield, Thompson, and Turpin (2005) used the Implicit 
Association Test to examine implicit attitudes toward individuals with dermatological 
conditions and identified an implicit preference for clear skin. Across disfiguring 
diseases, patients with facial disfigurement report fear of negative evaluation and social 
avoidance and challenges maintaining social interactions (Newell & Marks, 2000; 
Pruzinsky, 1992). Pruzinsky (1992) reported that the stigmatization of individuals with 
visible differences can even extend to intimate relationships.  
2.3 The Assessment of Body Image 
With the growing interest in body image research, there has been a concomitant 
growth in the assessment of the body image construct. Speaking of this symbiotic 
relationship, Thompson (2004) explained that, “As it often happens in science, such a 
phenomenon both stimulates and is fueled by the development of new measurement 
indices. In the case of body image, the exponential increase in the number of new and 
revised measures purporting to assess one or more multiple dimensions of body image 
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has been well documented” (p. 7). The sheer number of terms used to describe the 
specific body image dimension of interest (e.g., [dis]satisfaction, orientation, quality of 
life, distress, disturbance, esteem, shame) can be formidable for a researcher, let alone the 
number of validated measures. Thompson, Roehrig, Cafri, and Heinberg (2005) described 
some of the most commonly used measures for the assessment of body image in eating 
disorders and separated these in terms of whether they assessed an affective, behavioral, 
perceptual, or cognitive dimension of body image. Examples of the most common 
measures of body image used in general populations included the Body Image Quality of 
Life Inventory (Cash & Fleming, 2002), which explores how body image affects 19 life 
domains, the Body Image Ideals Questionnaire (Szymanski & Cash, 1995), which elicits 
ratings of an individual’s specific attributes from their individual viewpoint and that of a 
romantic partner, and the Multidimensional Body-Self Relations Questionnaire 
(MBSRQ; Cash, Wintstead, & Janda, 1986), a measure of ten subscales, including 
Evaluation, Orientation, Fitness, Health/Illness, Overweight Preoccupation, Self-
Classified Weight, and the Body Areas Satisfaction Scale (BASS; Cash, 2000). However, 
there is no “gold standard” assessment of body image. There are also assessments that 
seek to capture the more pathological experience of body image distress, disturbance, or 
dysmorphia. For example, the Body Image Disturbance Questionnaire (BIDQ; Cash, 
Phillips, Santos, & Hrabosky, 2004c) measures preoccupation with physical appearance, 
emotional distress, avoidance behavior, and the functioning burden of body image 
concerns.   
 Thompson (2004) warned of common pitfalls in body image research, which are 
arguably germane in non-eating disorders contexts, given the relative dearth of prior 
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research and models from which to pull. He noted that the following ten strategies would 
help to mitigate some of the most common measurement problems:  
1) Identify the specific dimension of body image being investigated (e.g., 
satisfaction with a particular body part); 
2) Use several measures of body image to capture multiple dimensions of body 
image;1 
3) Ensure that measures have established psychometric properties (e.g., validity); 
4) Ensure that measures have demonstrated validity specifically for your 
population (e.g., rheumatologic disease); 
5) Ensure that measure have demonstrated validity for your sample; 
6) Consider whether a slight change of wording may better answer your research 
question if the measure is focused on weight/shape/size; this may be a better 
alternative to creating a new measure altogether; 
7) Consider if a state or trait measure of body image is more appropriate for your 
research question; 
8) Ensure that the instructional protocol is not vague; 
9) Consider whether subgroup analyses (e.g., for gender) would be more 
appropriate; 
10) Evaluate data in the context of norms and clinical significance. 
The above are meant to signify best practices in assessments for body image research. 
Although it may not be possible to ensure that each criterion is met, particularly in cases 
                                                 
1 Thompson (2004) further added that because many of the body image constructs are orthogonal to each 
other (e.g., investment and orientation), multicollinearity among measures for certain analyses (e.g., 
regression) is typically not a concern.  
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where the researcher is using preexisting data, aiming to meet the criteria and noting as a 
limitation instances where they cannot be met, can bolster the quality of the research.  
There has been a growing interest in the disease-specific assessment of body 
image in populations reflecting physical illness and visible differences. In fact, Cash and 
Smolak (2011) referred to body image research in medical contexts as, “one of the new 
frontiers of scholarship” (p. 8). Body image is a relevant construct in the rare connective 
tissue disease SSc given that disfigurement is a "central feature" of the disease (Thombs 
et al., 2010, p. 1183). A brief overview of the epidemiology of SSc and a summary of the 
extant research on body image in SSc will be provided below.  
2.4 Body Image in Systemic Sclerosis  
The epidemiology and etiology of SSc. SSc is a multisystem, autoimmune 
connective tissue disease of unknown etiology characterized by antibody production, 
vasculopathy of the small vessels, and excessive deposition of collagen (Seibold, 2005; 
Wigley & Hummers, 2003). Organ involvement most commonly incudes the kidneys, 
esophagus, heart, and lungs, with lung involvement being the most common cause of 
death (Gabrielli, Avvedimento, & Krieg, 2009). It is estimated that the prevalence of SSc 
ranges from 50 to 300 cases per one million persons, with incidence ranging from 2.3 to 
22.8 new cases per one million persons annually (Chifflot, Fautrel, Sordet, Chatelus, & 
Sibilia, 2008). Women are 4.6 time as likely as men to have SSc (Mayes et al., 2003). 
Black individuals have slightly higher odds (1.15, 95% CI 1.02-1.30) of being affected 
with SSc than White individuals, and are significantly younger at diagnosis than White 
individuals (Mayes et al., 2003). To contextualize the rarity of the condition, the 
prevalence of rheumatoid arthritis (RA), SLE, and SSc among U.S. adults is estimated at 
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1.3 million, 161,000 to 322,000, and 49,000, respectively (Helmick et al., 2008). SSc is 
complex and highly heterogeneous in its presentation.  
 There is no gold-standard measure of severity in SSc, precisely because the 
disease can present heterogeneously and involve different organ systems (Hudson, Steele, 
Canadian Scleroderma Research Group, & Baron, 2007). There are, however, commonly 
used proxies for disease severity, including forced vital lung capacity and skin thickness 
(Hudson et al., 2007). The classification of such a heterogeneous disease can also be a 
challenge. As elegantly described by LeRoy and colleagues (1988), whereas disease itself 
is a “pathobiologic continuum,” disease classification is “…a heuristic, compartmental 
exercise dependent on limited current understanding.” They continued, “For those who 
venture to classify, subsets so defined should make a difference to the patient in outcome, 
to the health professional in intervention and surveillance, and to the investigator for 
suitable subjects for study” (p. 202).  
There is a widely used, well-accepted, and clinically meaningful disease subtype 
classification in SSc between limited cutaneous and diffuse cutaneous disease. In limited 
disease, skin thickening is typically constrained to the, hands, arms, and/or face; if organ 
involvement is present, it typically has a very delayed (i.e., several decades) onset; in 
diffuse disease, the skin involvement is widespread, including the trunk, and can include 
progression and serious organ complications (Gabrielli et al., 2009; Steen, Powell, & 
Medsger, 1988).  
 There is no known cause of SSc. A qualitative study (Gholizadeh et al., 2015a) 
explored patient attributions of scleroderma origin and identified that seven themes were 
most commonly involved in patient theories of etiology: (i) stress; (ii) environment; (iii) 
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genetics; (iv) medical conditions; (v) diet; (vi) substance use; and (vii) spirituality. There 
have been theories linking environmental exposures to SSc, with silica exposure being 
linked to a significantly higher risk of developing in SSc in two studies (Makol, Reilly, & 
Rosenman, 2011; McCormic et al., 2010), however such environmental disease triggers 
are associated with a small proportion of total cases (Barnes & Mayes, 2012). Other 
studies have identified genetic risk factors (e.g., Gorlova et al., 2011), however the cause 
and underlying mechanisms of the disease remain unknown.  
Scleroderma-related visible differences. Scleroderma is derived from the Greek 
words skleros (hard) and dermos (skin), with the hardening of skin being a manifestation 
of excessive collagen production (Seibold, 2005). In addition to the hardening of the skin, 
other appearance changes can include the following (Malcarne et al., 1999):  
1. Loss of skin folds; 
2. Shiny appearance to the skin; 
3. Hypo- or hyper-pigmentation of the skin; 
4. Loss of flexibility of the lips and decreased ability to fully open the 
mouth; 
5. Pinched appearance to the nose and eyes; 
6. Telangiectasias; 
7. Subcutaneous calcinosis, often in the fingers, elbows, and knees;  
8. Sclerodactyly; 
9. Deformity of the digits; 
10. Limited range of motion in the hands caused by contractures and/or non-
healing ulcers, or surgical amputation to manage digital ischemia.  
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Jolly (2011) noted that weight loss is also common and may, “remind patients of their 
disease, leading to fears that they will visibly deteriorate not be able to recognize 
themselves” (p. 354).  
Although there can be a great deal of heterogeneity in the type, location, and 
severity of skin involvement in SSc, many patients do experience a similar change in the 
facial experience involving tightened skin, a pinched nose, and shrunken mouth opening 
(referred to as a “Mauskopf’ appearance in the medical literature; Amin et al., 2011). 
Amin et al. (2011) used ratings of digital photographs of scleroderma patients’ faces by 
health professionals to examine the relationship between objective ratings of severity and 
patient perceptions of noticeability. The authors found a high concordance such that as 
the observer ratings increased in severity, so did individual-reported perceptions of 
noticeability and scores on a measure of social concerns and anxiety. The authors noted 
that this finding was interesting because in many other disfiguring conditions, there is 
greater variance between objective and subjective severity. They posited that, “…there is 
closer agreement between the subjective rating of appearance and rating by an observer 
than in other disfiguring conditions; the characteristic ‘Mauskopf’ appearance for 
example may focus attention to one feature rather than many, providing essentially a 
unitary dimension of change and reducing inter-rater variability” (p. 310).  
It has been opined that this similarity in disfigurement may also contribute to 
increased fear of progression among newly diagnosed patients experiencing changes in 
appearance who observe more severe versions of their own changes in their peers 
(Gholizadeh, Fox, Mills, Jewett, Thombs, & Malcarne, 2017a). Anecdotally, this has 
been evidenced by patients who have reported avoiding potentially beneficial support 
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group meetings because of the increased anxiety elicited in seeing other patients with 
visibly advanced disease. In addition to facial involvement, hand involvement can also be 
especially challenging for patients. In one study, skin thickening on the fingers of the 
right hand was identified as the strongest predictor of poor self-esteem (Malcarne et al., 
1999). Because the hand and face are “socially relevant” (Benrud-Larson et al., 2003, p. 
131) and more readily noticeable areas of the body, it would be expected that 
disfigurement in these areas would lead to greater distress (Malcarne et al., 1999).  
Research in SSc has also demonstrated associations between body image 
dissatisfaction and poorer interpersonal functioning (Benrud-Larson et al., 2002; 
Kwakkenbos et al., 2012). The rarity of SSc can contribute to a sense of isolation and 
stigmatization in patients because others see visible signs that they do not understand but 
can recognize as different (Joachim & Acorn, 2003). In his seminal work on stigma, 
Goffman (1963) described physical disfigurement as one form of stigma. Living with a 
visible chronic illness, one does not have the choice of whether or not to disclose the 
illness, but rather the disclosure is inherent in the first social interaction. In one of the few 
studies to qualitatively explore stigmatization and other social experiences of living with 
SSc, Joachim and Acorn (2003) described, “Although coping with serious life-
threatening aspects of scleroderma, several participants stated that their major fear, a fear 
greater than dying from scleroderma, was being ‘ugly’ and looking bad to themselves and 
others. It is possible that being stigmatized, discredited and isolated was their real fear” 
(p. 603-4).  
Psychosocial impacts of SSc. Because a cure for SSc, a chronic and progressive 
condition, remains elusive, symptom reduction and health-related quality of life 
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improvement are treatment targets (Kwakkenbos et al., 2015a; Thombs et al., 2010). 
Thombs and colleagues (2010) reported that although the psychosocial challenges 
associated with SSc were pervasive and should be areas of clinical focus, the research on 
psychosocial impacts of the disease was relatively sparse, largely due to the low 
prevalence of SSc and a lack of validated psychosocial measures in SSc. Malcarne, Fox, 
Mills, and Gholizadeh (2013) echoed these claims, noting, however, that there had been 
substantial strides in psychosocial research and especially assessment efforts in 
scleroderma in even the three years since Thombs and colleagues’ important paper.  
 There are myriad psychosocial impacts of scleroderma, including increased 
depression and anxiety (Bodukam et al., 2011; Benrud-Larson et al., 2002; Hyphantis et 
al., 2007; Jewett, Razykov, Hudson, Baron, & Thombs, 2014; Legendre, Allanore, 
Ferrand, & Kahan, 2005; Richards, Herrick, Griffin, Gwilliam, & Fortune, 2004; 
Thombs, et al., In Press); fatigue (Assassi et al., 2011; Thombs et al., 2008a; Yacoub, 
Bensabbah, & Hahhah-Hassouni, 2012; Sandusky, McGuire, Smith, Wigley, & 
Haythornwaite, 2009); pain (Benrud-Larson et al., 2002; Del Rosso et al., 2004; 
Malcarne et al., 2007; Richards et al., 2003; Schieir et al., 2010); disability (Hudson et 
al., 2008; Malcarne et al., 2007; Müller, Rehberger, Günther, & Schmitt, 2012; Sharif et 
al., 2011), and sexual dysfunction (Bongi et al., 2013; Knafo, Haythornthwaite, Heinberg, 
Wigley, & Thombs, 2011; Levis et al., 2012a; Levis et al., 2012b; Schouffoer et al., 
2009). Additionally, body image impacts, such as dissatisfaction with appearance and 
lowered appearance-related self-esteem are common, as will be described in the 
following sections. Benrud-Larson et al. (2003) found that dissatisfaction with 
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appearance was prevalent in SSc patients, with SSc patients reporting greater body image 
dissatisfaction than burn injury survivors.  
Assessment of body image in SSc. In 2010, Thombs and colleagues highlighted 
the need for validated measures that explore various aspects of body image in 
scleroderma, such as body image avoidance. Prior to this call, the existing body image 
research using validated measures had been limited to the Satisfaction with Appearance 
Scale or the Adapted Satisfaction with Appearance Scale (e.g., in Benrud-Larson et al., 
2003 and Heinberg et al., 2007) and the appearance subscale of the State Self-Esteem 
Scale (e.g., in Malcarne et al., 1999 and Van Lankveld, Vonk, Teunissen, & van den 
Hoogen, 2007). In the past few years, however, there has been an increase in scholarship 
developing and using measures validated specifically in scleroderma to examine various 
aspects of body image (Malcarne et al., 2013).  
 At present, the following measures have been validated for use in SSc: the 
Satisfaction with Appearance Scale (SWAP; Lawrence et al., 1998), the Adapted 
Satisfaction with Appearance Scale (ASWAP; Heinberg et al., 2007), the Brief 
Satisfaction with Appearance Scale (Brief-SWAP; Jewett et al., 2010), the Derriford 
Appearance Scale short-form (DAS-24; Carr, Moss, & Harris, 2005), the Body 
Concealment Scale for Scleroderma (BCSS; Jewett et al., 2016b), and the Appearance 
Subscale of the State Self-Esteem Scale (SSES; Heatherton & Polivy, 1991).  
Presence and Correlates of Body Image (Dis)satisfaction in Scleroderma. 
Fourteen studies have explored the presence and correlates of some dimension of the 
body image construct, with a burgeoning of scholarly interest in this area in the last 
several years (Amin et al., 2011; Benrud-Larson et al., 2003; Ennis, Herrick, Cassidy, 
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Griffiths, & Richards, 2012; Jewett et al., 2010; Jewett et al., 2012a; Jewett et al., 2016a; 
Heinberg et al., 2007; Knafo, Haythornthwaite, Heinberg, Wigley, & Thombs, 2011; 
Kwakkenbos et al., 2012; Leite & Maia, 2013; Malcarne et al., 1999; Mills et al., 2015b; 
Nusbaum, Gordon, & Steen, 2016; Van Lankveld, Vonk,Teunissen, & van den Hoogen, 
2007). Nine of the aforementioned fourteen studies used some variation of the SWAP and 
two used the appearance self-esteem subscale of the SSES, as their outcomes of interest.  
 The majority of the research has been limited to (dis)satisfaction with appearance 
and appearance-related self-esteem as the body image dimension of interest. In previous 
research examining specific aspects of appearance and body image, face tightening 
(Benrud-Larson et al., 2003), skin tightening above the elbows (Benrud-Larson et al., 
2003), skin tightening above the knees (Benrud-Larson et al., 2003), face involvement 
(Jewett et al., 2012), finger restriction (Benrud-Larson et al., 2003), skin thickening of the 
right hand and fingers (Malcarne et al., 1999), and telangiectasias (Ennis et al., 2013) 
have been significant correlates of body image dissatisfaction and associated 
psychological distress. Jewett et al. (2012) explored correlates of Dissatisfaction with 
Appearance (DA) and Social Discomfort (SD) via structural equation modeling, and 
found that face involvement and fingertip-to-palm distance were significant predictors of 
DA, whereas age, telangiectasias, and face involvement were significant correlates of SD. 
 Studies have also examined demographic correlates of body image dissatisfaction. 
Younger age has been associated with overall body image dissatisfaction (Benrud-Larson 
et al., 2003). However, two studies disentangling the personal (SWAP-DA) from social 
components (SWAP-SD) of body image dissatisfaction found that younger age was only 
significantly associated with SD but not DA (Jewett et al., 2012; Ennis et al., 2013). 
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Marital status, ethnicity, sex, and education were not associated with body image 
dissatisfaction via the Brief-Swap (Jewett et al., 2012a). However, Ennis et al. (2013) 
found that being single was associated with higher total and subscale ASWAP scores 
(i.e., body image distress) and being retired was associated with higher DA scores. In a 
recent study examining racial identity and body image dissatisfaction, Nusbaum et al. 
(2016) found that African American patients with SSc had significantly higher rates of 
body image dissatisfaction than Caucasian participants. Of note, a validated measure of 
body image dissatisfaction was not used in the Nusbaum et al. (2016) study; instead, 
Likert scales assessed dissatisfaction with specific features (e.g., changes in 
pigmentation) and the scores were summed to form a composite dissatisfaction index.  
In terms of clinical correlates of body image dissatisfaction, being diagnosed with 
the diffuse disease subtype (Benrud-Larson et al., 2003; Ennis et al., 2013; Heniberg et 
al., 2008), younger age at first non-Raynaud’s2 symptom (Ennis et al., 2013), higher 
modified Rodanan skin scores (mRss, a measure of skin involvement in SSc; Jewett et 
al., 2012; Mills et al., 2015a), and greater bodily pain (Benrud-Larson et al., 2003; 
Heinberg et al., 2008; Jewett et al., 2013) were associated with greater body image 
dissatisfaction. The literature has had some discordance, however. For example, Mills et 
al. (2015a) did not find a significant association for pain and body image and van 
Lankfeld et al. (2007) did not find an association between mRss and appearance-related 
self-esteem.  
                                                 
2 Time from first non-Rayanud’s symptom, rather than time since diagnosis, is commonly used as a proxy 
for disease duration in scleroderma given the often-lengthy time between symptom onset and ultimate 
diagnosis.  
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 The psychosocial correlates of body image dissatisfaction have been a growing 
focus of scholarly research in SSc. Previous studies have demonstrated moderate positive 
associations between depression scores and body image dissatisfaction (Benrud-Larson et 
al., 2003; Jewett et al., 2010; Kwakkenbos et al., 2013; Leite et al., 2013) and small to 
moderate positive correlations of body image dissatisfaction with functional 
deficits/disability (Benrud-Larson et al., 2003; Heinberg et al., 2008; Mills et al., 2015a). 
Other correlates of body image dissatisfaction have been poorer functioning via SF-36 
mental and physical composite scores (Jewett et al., 2013; Mills et al., 2015a); higher 
social phobia scores (Leite et al., 2013), higher anxiety scores (Leite et al., 2013); more 
body concealment behaviors (Jewett et all, 2015); poorer adjustment to illness (Benrud-
Larson et al., 2003); and sexual dysfunction (Knafo et al., 2011). Malcarne et al. (1999) 
also found a significant relationship between lower appearance-related self-esteem and 
poorer adjustment to illness.  
The majority of this research has involved univariate analyses. However, in the 
aforementioned Jewett et al. (2012) study that examined correlates of body image 
dissatisfaction, the authors also examined the relationships among the body image 
dissatisfaction outcome variable and its correlates via structural equation modeling and 
found that after the inclusion of face involvement into their model, no other variables 
were significant predictors of body image dissatisfaction. Another study additionally 
found via path analysis that depression mediated the relationship between body image 
dissatisfaction and psychosocial functioning (Benrud-Larson et al., 2003); of note, this 
study was a cross-sectional design, precluding conclusions about true mediation.  
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In sum, the extant literature on body image in scleroderma has been 
predominantly based on univariate studies, and the results have not always been 
consistent. For example, younger age was associated with poorer body image scores in 
two studies (Benrud-Larson et al., 2003; Jewett et al., 2012); however, Leite et al. (2013) 
found no relationship with age. Pain had a small-moderate correlation with poorer body 
image in three studies (Benrud-Larson et al., 2003; Jewett et al., 2015; Heinberg et al., 
2007), however Mills et al. (2015b) found no relationship with pain. Additionally, the 
few studies engaging in more advanced statistical methods have found more complex 
relationships that were not identified using less advanced statistical methods.  
State of Scleroderma Body Image Research. Despite the prevalence of and 
distress associated with changes in appearance in SSc, our understanding of the 
experience of body image in this disease remains limited (Malcarne, Fox, Mills, & 
Gholizadeh, 2013; Thombs et al., 2010). While there have been several studies 
identifying bivariate correlates of body image distress, and a smaller number using more 
advanced methods, there is a need for an examination that more fully allows the complex 
relationships among personal and social aspects of bodily changes to be identified. 
Because previous body image research has demonstrated that there is not always a simple 
relationship such that more severe disfigurement means more body image distress 
(Robinson, 1997; Rumsey, Clarke, & Musa, 2002), it cannot be assumed that patients 
with more severe disease will be the ones experiencing more problems with appearance 
impacts. There is a need for multivariate research that seeks to better understand the 
complex construct of body image in SSc in order to best serve the needs of patients.  
  An important first step is the identification of patient groups based on 
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multidimensional profiles of variables related to appearance changes and body image 
distress. This would help to identify distinct patient groups that may exist. For example, 
there may patients whose disease experience does not include social challenges but who 
report high levels of personal body image distress, versus other patients for whom both 
personal and social aspects are problematic. There may be variations in the interplay 
between body image and social anxiety that define distinct patient groups. Developing a 
better understanding of the appearance-related experiences of patients with SSc requires 
using sophisticated data analytic procedures that allow the identification of groups across 
multiple personal and social aspects of appearance-related distress. A complex construct, 
such as body image, lends well to a symptom cluster-like approach where clusters are 
defined as symptoms that are typically interrelated and have a synergistic impact on 
outcomes that is distinct from the relationship between any one individual symptom and 
the outcome (Barsevick, Whitmer, Nail, Beck, & Dudley, 2006). A statistical procedure 
that allows such an approach and would enhance our understanding of how the personal 
and social aspects of body image relate in SSc is latent profile analysis (LPA). 
2.5 Latent Profile Analysis  
With greater advancements in and accessibility of multivariate statistical 
techniques, such as LPA and latent class analysis (LCA), examining more intricate 
relationships among variables is possible. LPA has become increasingly common in the 
behavioral and social sciences (Nylund, Asparouhov, & Muthén, 2007). LPA is a useful 
approach to examining potentially complex interactions given that the interpretation of 
numerous higher-order interactions via variable-centered analyses can be difficult and 
statically problematic because of issues such as variance inflation factor elevations 
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(Cohen, Cohen, West, &, Aiken, 2003; Merz & Roesch, 2012). Contrastingly, a person-
centered approach, such as LPA, can enable a more accessible interpretation of the 
relationships among variables at the level of the person rather than the variable (Roesch, 
Villodas, & Villodas, 2010). LPA is a branch of mixture modeling that enables the 
classification of subgroups of participants that demonstrate similar response patterns to a 
set of observed variables, called indicator variables. LPA allows for the inclusion of 
continuous indicator variables, while LCA is limited to categorical indicator variables. 
The distinction between LPA and LCA is not rigidly demarcated (Hagenaars & 
McCutcheon, 2002) and the two analyses can be combined (Kongsted & Nielsen, 2016). 
Via maximum likelihood estimation, LPA uses all observations of the continuous 
indicator variables to determine classes (Little & Rubin, 1987). Classes are added 
iteratively to determine optimal model fit; overall model fit and probability of correct 
individual classification are estimated simultaneously (Hill, Degnan, Calkins, & Keane, 
2006).  
Barsevick, Whitmer, Nail, Beck, and Dudley (2006) differentiated between a 
“symptom” as a single indicator of disease, versus “symptom clusters” that are 
“concurrent and related symptoms…[that] can be related through a common mechanism 
or etiology, by sharing common variance, or by producing different outcomes than 
individual symptoms” (p. 86). Barsevick et al. (2006) further noted that that symptom 
clusters are of diagnostic importance and many psychiatric conditions are diagnosed on 
the basis of symptoms (e.g., depressed mood; weight gain; fatigue). For the present 
purposes, the personal and social aspects of body image can be construed as experience 
symtoms that would lend well to a cluster approach.  
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Symptom cluster groups can then be used in many ways, for example examining 
differences among groups by relevant predictors of group membership, reducing the 
number of required variables and sample size in an analysis, and identifying patients most 
likely to benefit in an intervention (Clatworthy, Hankins, Buick, Weinman & Horne, 
2007). In psychosocial research, cluster analysis is one approach to the derivation of 
psychological profiles, but there are some limitations to this approach, including 1) lack 
of clear guidelines to decide on the number of clusters; 2) analysis sensitive to 
distributions and measurement scales; 3) difficult-to-meet assumptions (e.g., class-
invariant classes; Milligan & Cooper, 1987; Morin, Morizot, Boudrias, & Madore, 2011; 
Speece, 1994). LPA and LCA do not assume that relationships among variables are 
homogenous for all patients and instead enable a probabilistic approach that gives each 
individual a probability of belonging to a given subgroup (Kongsted & Nielsen, 2016).  
LPA/LCA in the behavioral medicine and body image contexts. LPA and 
LCA are useful tools in the behavioral medicine and body image contexts given the 
potential to derive groups of patients with similar characteristics. Despite this, LPA/LCA 
have been minimally used in the context of body image. Moreover, the studies that do 
exist tend to focus on eating disordered populations. Jacobs and colleagues (2009) used 
LPA to identify behavioral profiles of patients with anorexia nervosa (AN), referred to as 
probands, and their parents with the goal of identifying “cross-generational clusters of 
behavioral traits” (p. 452) present in the individuals with AN and their parents. Three 
distinct profiles of families were identified distinguishing among: 1) moderate 
symptomatology in probands but healthy mothers, 2) the highest symptomatology in 
probands and moderate symptomatology in mothers, and 3) high symptomatology in 
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probands and high symptomatology in mothers. One-way ANOVAs were conducted as 
means of external validation to supplement statistical significance of groups with clinical 
significance, but failed to find significant differences.  
Hildebrandt, Schlundt, Langenbucher, and Chung (2006) examined muscle 
dysmorphic symptoms in male weightlifters (N = 237) via an LCA of eight measures of 
body image and appearance-related anxiety and identified five distinct classes of 
respondents: 1) Dysmorphic, 2) Muscle Concerned, 3) Fat Concerned, 4) Normal 
Behavioral, and 5) Normal.  Hildebrandt et al. also conducted one-way ANOVAs to 
identify between-group “external validators,” such as the presence of eating disordered 
behaviors and steroid use (p. 132). Through the LCA and follow-up ANOVAs, 
Hildebrandt et al. characterized the groups as qualitatively distinct; for example, the 
dysmorphic group, “desired to decrease body fat and increase muscle mass, and had the 
highest scores across dimensions of body image disturbance, associated 
psychopathology, and appearance-controlling behaviors” (p. 133). Furthermore, this 
group had higher rates of steroid use compared to the other identified groups. 
Lanza, Savage, and Birch (2010) used LCA in sample of women (N = 197) to 
identify classes of weight loss strategies. They identified four distinct subgroups: 1) No 
Weight Loss Strategy, 2) Dietary Guidelines, 3) Guidelines + Macronutrients, and 4) 
Guidelines + Macronutrients + Restrictive. The groups differed on key psychosocial 
variables, for example, weight concerns and desire to be thinner were more strongly 
predictive of membership in the Guidelines + Macronutrients + Restrictive group than 
the No Weight Loss Strategy group. Brytek-Matera, Rogoza, Gramaglia, and Zeppegno 
(2015) also used LCA to examine problematic eating behaviors in a small sample (N = 
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52) of women with eating disorders and used the MBSRQ as one of the measures in the 
LCA; however, the methodological quality of the study was questionable, and although 
they identified a two-class solution, it was not clearly described in the paper.  
Selected studies in rheumatologic conditions are also provided to further illustrate 
the utility of LCA/LPA in behavioral medicine contexts. LPA has also been used to 
classify rheumatologic patients into symptom specific profiles. For example, Sullivan, 
Smith, and Buchwald (2011) entered over thirty symptoms commonly reported by 
fibromyalgia and chronic fatigue patients into an LCA and identified a four-class solution 
where individuals differed not qualitatively in symptomatology but rather on a severity 
gradient, suggesting a greater similarity between chronic fatigue and fibromyalgia 
patients than previously considered. Wilson et al. (2001) examined psychological and 
clinical symptoms in a sample of patients with chronic fatigue syndrome and identified 
one group in which individuals tended to be younger in age, have a smaller female to 
male ratio, have a shorter episode duration, and less psychiatric symptomatology and 
lower functional disability as compared to the second group. The second group also 
reported a higher prevalence of atypical symptoms (e.g., vision loss) and less 
responsiveness to factors expected to improve symptoms (e.g., sleep). The second class 
was therefore conceptualized as more akin to somatoform disorder than chronic fatigue 
syndrome.  
In rheumatoid arthritis (RA) previous research has explored pain and adjustment 
profiles to identify “Adaptors” (i.e., individuals with greater perceptions of control and 
lower perceptions of pain-related consequences of the disease and disease chronicity) and 
“Non-adaptors” (i.e. individuals with lower perceptions of control and stronger 
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perceptions of disease chronicity, recurrence, and identity; Hobro, Weinman, & Hankins, 
2004). Norton et al. (2014) used LPA in a sample of RA patients (N = 227) and also 
identified two classes (unnamed) corresponding to adaptors and non-adaptors, wherein 
the non-adaptor-like group had greater negative representations of disease, endorsement 
of more symptoms, less control, and more severe perceived consequences as compared to 
the adaptors. The non-adapter-like group’s membership predicted higher pain and 
functional disability. 
LPA has been used in SSc in one study. Using LPA to explore pain profiles in 
SSc, Merz et al. (2014) found that SSc patients could be divided into three 
biopsyschosocial typologies in relation to their pain:  1) Managing, 2) Resilient, and 3) 
Distressed. The Managing group was characterized by relatively less severe disease, 
better perceived physical health, fewer health worries, better mental health, and more 
social support. The Resilient group was characterized by relatively greater disease 
severity and poorer perceptions of health, but also fewer health worries, better mental 
health, and more social support. The Distressed group was characterized by relatively 
less severe disease, but poorer perceptions of health, more health worries, poorer mental 
health, and lower social support. In other words, individuals in the Distressed group had 
objectively less severe disease than the Resilient group, but their subjective reports of 
pain and medication utilization were higher. This finding is important because it suggests 
that disease severity alone was not the best way to identify patients who were at greater 
risk for pain-related problems and medication use; rather, profiles revealed that 
psychosocial variables, such as mental health and social support, helped to distinguish 
which patients were most at risk for pain problems. Thus, LPA is a tool that can identify 
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groups of patients with different needs and challenges. This is especially important in a 
context where severity does not necessarily directly correlate with level of distress, and 
examination of simple bivariate relationships may obscure more complex relationships 
among disease parameters.  In these cases, LPA can identify profiles of patients across 
multiple indicators, revealing more complex patterns than can be garnered from other, 
simpler analyses. 
2.6 Summary and Limitations of Prior Research 
Changes in appearance are a common and distressing aspect of SSc for many 
patients (Thombs et al., 2010). Living with SSc presents unique challenges for patients 
given the increased potential for stigmatization (Joachim & Acorn, 2003) and lack of 
relevant and accessible resources, especially relating to psychosocial concerns (Thombs 
et al., 2010). Despite the fact that there has been increased attention to the psychosocial 
impacts of SSc, there are still many gaps in the understanding of SSc-related body image 
distress and associated outcomes (Malcarne et al., 2013). 
The literature exploring body image in SSc has been inconclusive and few studies 
have used multivariate methods. Only one previous study has used LPA in SSc (Merz et 
al., 2014), and this was in the context of deriving pain typologies. As a preferred 
analytical tool for making complex inferences about individuals (Roesch et al., 2010), 
LPA is an approach that would enable a more refined understanding of the 
multidimensional experience of body image in SSc.   
2.7 Specific Aims and Hypotheses of the Present Study 
The present study aimed to establish typologies of patients with SSc based on 
multiple indicators of body image and social anxiety, and to examine differences among 
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identified groups across sociodemographic, medical, and psychosocial variables. 
Specifically, the present study had the following specific aims:  
Specific Aim 1. To establish typologies of patients based on multiple 
indicators of body image and social anxiety. The first aim of the present study was to 
establish profiles (i.e., typologies) of patients based on multiple indicators of body image 
and social anxiety in SSc. Prior to running the analysis, the sample was randomized into 
two different groups to allow for a replication analysis of the findings. Exploratory LPA 
was used to derive categorical latent variables that signified profiles of similarly scoring 
individuals using subjective indicators of body image and social anxiety and one 
objective indicator of skin involvement. LPA is an exploratory approach, precluding 
hypotheses regarding which exact classes will emerge from the data. However, it was 
hypothesized that the analysis would uncover multiple (i.e., greater than two) unique 
profiles of patients based on the different dimensions of body image and social anxiety. It 
was also hypothesized that the objective skin involvement indicator would not 
necessarily be directly associated with uniformly poorer body image and social anxiety 
scores per the aforementioned research demonstrating that the severity of disfigurement 
does not directly relate to psychosocial outcomes (Rumsey, 2002a, 2002b). It was further 
hypothesized that profiles may emerge differentiating 1) individuals with similar 
objective skin involvement scores but differing subjective dissatisfaction and social 
anxiety scores, and 2) similar personal dissatisfaction scores but differing social anxiety 
scores. Furthermore, it was hypothesized that the number of typologies identified would 
be replicable between both samples.  
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Specific Aim 2. To examine the profiles in relation to sociodemographic 
medical, and psychosocial variables. The second aim of the present study was to 
evaluate potential differences in sociodemographic (e.g., age) medical (e.g., disease 
duration) and psychosocial variables (e.g., depression) as a function of profile 
membership. These group comparison variables are referred to as auxiliary variables 
(Lanza, Tan, & Bray, 2013). It was hypothesized, per the previous research on correlates 
of body image, that if groups emerged that indicated greater body image distress and 
social anxiety, they would be associated with female gender, Black/African American 
race, lower age, higher disease duration, greater depression, greater anxiety, greater 
disability, the diffuse disease subtype, and the presence of disease variables reflecting 
disfigurement in the face and hands. It was hypothesized that the other auxiliary variables 
(i.e., marital status, year’s since first non-Raynaud’s symptom, year’s since diagnosis, 
BMI) would not significantly differ across identified groups. Also, it was hypothesized 
that if resilient-type groups emerged such that there were participants who had relatively 
high objective skin involvement but had relatively better body image and/or social 
anxiety scores, patients in this group would have better mental health (e.g., depression, 
anxiety) as compared to group(s) high in not only objective skin involvement but also 
dissatisfaction and social anxiety. Furthermore, it was hypothesized that these 
relationships would be similar in the two randomized samples.  
Chapter 2 is being prepared in part for publication. This publication will be co-
authored by Vanessa L. Malcarne, Scott C. Roesch, Marie-Eve Carrier, Linda 
Kwakkenbos, Sarah D. Mills, Rina S. Fox, and Brett D. Thombs.. The dissertation author 
was the primary investigator and author of this material. 
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CHAPTER 3: METHODS 
3.1 Participants 
 Patients in the SPIN Cohort were enrolled at 28 centers from Canada, the United 
States, and the United Kingdom. To be eligible for the SPIN Cohort, patients must have a 
diagnosis of SSc according to the 2013 ACR/EULAR classification criteria (van den 
Hoogen et al., 2013) confirmed by a SPIN physician, be at least 18 years of age, have the 
ability to give informed consent, and be fluent in English or French. Exclusion criteria for 
participation in the SPIN Cohort include not having access to the internet or otherwise 
not being able to respond to questionnaires via the internet. Only participants who 
completed the core indicator measures used in the LPA and had physician-documented 
limited or diffuse disease were included in the present analysis.  
A total of 1343 patients completed study questionnaires from April 2014 through 
October 2016. One participant who was not an English or French speaker was excluded 
from the analysis. Participants for whom disease subtype (i.e., limited, diffuse) was not 
provided or who were classified as the subtype “sine”, a relatively rare classification that 
refers to patients with some of the visceral impacts of SSc but without the skin 
involvement (Poormoghim, Lucas, Fertig, & Medsger, 2000), were removed (n = 43). 
The research on how to best classify sine patients (i.e., as having an entirely different 
disease; as constituting a rare, unique disease subtype; or as having an early form of 
limited SSc; Hachulla & Launay, 2011) is still inconclusive and as such these patients 
were excluded. One hundred and twenty patients with missing data on one or more of the 
core body image or social anxiety measure included in the LPA were excluded. Two 
hundred and 
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thirty-seven patients without mRss data were also excluded from the present sample. 
Thus, the study sample consisted of 942 patients enrolled in the Scleroderma Patient-
centered Intervention Network (SPIN) Cohort. Differences between individuals included 
in the present analysis and those excluded were examined with chi-squared (for 
categorical variables) and t-test (for continuous variables) analyses. There were no 
significant differences by age, gender, race, marital status, years of education, or time 
since diagnosis. There was a significant difference in years since first non-Raynaud’s 
symptom such that excluded participants had a significantly longer duration of 
experiencing symptoms t(149) = -2.13, p = .008; M (SD) = 12.29 (9.3) vs. 11.10 (8.4). 
The SPIN sample is a convenience sample. Eligible patients are invited by the 
attending physician or a supervised nurse coordinator to participate in the SPIN Cohort, 
and written informed consent is obtained. The local SPIN physician or supervised nurse 
coordinator then completes a medical data form that is submitted online to initiate patient 
registration in the SPIN Cohort. After completion of online registration, an automated 
welcome email is sent to participants with instructions to on how to activate their SPIN 
online account and how to complete the SPIN Cohort patient measures online. SPIN 
Cohort patients complete outcome measures via the internet upon enrollment and 
subsequently every 3 months. The SPIN Cohort study was approved by the Research 
Ethics Committee of the Jewish General Hospital, Montreal, Canada and by the 
Institutional Reviews Boards of each participating center. The analysis involved archival, 
de-identified data and was thus exempt from IRB review at SDSU/UC San Diego.  
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3.2 Study Procedures  
Attending physicians or supervised nurse coordinators trained in SPIN 
recruitment procedures informed eligible patients about SPIN and enter eligible and 
interested patients into the SPIN cohort (see Appendix A for a description of the cohort) 
and obtain written informed consent (Kwakkenbos et al., 2013). A medical data form for 
the patient was submitted by the associated SPIN physician or nurse coordinator, after 
which point participation was initiated and the patient received an email inviting them to 
the study with study instructions. Upon enrollment, SPIN cohort patients completed the 
baseline questionnaires. Patients were asked to complete a series of measures every three 
months as part of participation in the cohort. For the present analysis, all patients with 
baseline data for the selected indicator variables were included. 
3.3 Measures 
Sociodemographic and medical variables. Age, gender, race, marital status, 
educational attainment, occupational status, and BMI were assessed via self-report. Given 
the multi-country nature of the present study, the various country-specific racial 
identifications were re-coded into White/Caucasian, Black/African-American, and All 
Other. Disease duration (i.e., date from first non-Raynaud’s symptom), disease subset 
(limited/diffuse), and various appearance-related variables (dichotomous variables 
reporting the presence/absence of sclerodactyly, lower hand thickening, fingertip scars, 
telangiectasias, and pigmentation) were physician reported. Sclerodactyly referred to a 
localized tightening distal to the four metacarpophalangeal joints but proximal to the 
proximal interphalangeal joints. Lower hand thickening referred to skin thickening of the 
fingers of both hands extending proximal to the metacarpophalangeal joints. Fingertip 
  33 
scars specifically referred to fingertip pitting scars that involve depressed areas at digital 
tips as a result of ischemia, rather than trauma or exogenous causes. Telangiectasias 
referred to widened blood vessels anywhere on the body. Pigmentation included the 
presence of either hypo- or hyper-pigmentation anywhere on the body.  
Body image and social anxiety variables. Body Concealment Scale for 
Scleroderma (BCSS; Jewett et al., 2016b). The BCSS is a nine-item measure of body 
concealment and avoidance that was developed from the Body Image Avoidance 
Questionnaire (Rosen, Srebnik, Saltzberg, & Wendt, 1991). Body concealment can be 
used as an avoidance strategy by individuals living with visible differences (Jewett et al., 
2017). The measure is scored as a total sum of the nine items. Respondents rank on a 
response scale ranging from 0 (never) to 5 (always) how often they engage in various 
concealment behaviors, with higher scores indicating higher frequency of body 
concealment behaviors.  Sample items include, “I wear clothes to hide the changes to my 
skin,” and “I wear gloves to hide my hands.” The measure was specifically developed for 
SSc populations by Jewett et al. (2016b) and has shown strong internal consistency and 
good construct validity in replication with the SPIN SSc population as well (Jewett et al., 
2017). In the present sample, the internal consistency for Samples 1 and 2 was α = 0.89 
and α = 0.88, respectively.  
Brief-Satisfaction with Appearance Scale (Brief-SWAP; Jewett et al., 2010). The 
Brief-SWAP is a disease-specific, 6-item measure of body image dissatisfaction derived 
from the 14-item SWAP (Lawrence, Heinberg, Roca, Munster, Spence, & Fauerbach, 
1998). The Brief-Swap has two three-item subscales Dissatisfaction with Appearance and 
Social Discomfort. Responses are on a Likert-type scale ranging from 0 (strongly 
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disagree) to 6 (strongly agree) with each subscale score ranging from 0-18, with higher 
scores indicating greater dissatisfaction and discomfort. Sample items for Dissatisfaction 
with Appearance and Social Discomfort scales include, “I am satisfied with the 
appearance of my hands,” (item is reverse scored) and “I feel that my scleroderma is 
unattractive to others.” Psychometric analyses have demonstrated that the measure is 
reliable and valid in SSc (Jewett et al., 2010; Mills et al., 2015b). In the present sample, 
the internal consistency for the Dissatisfaction with Appearance subscale in Samples 1 
and 2 was α = 0.82 and α = 0.81, respectively; the internal consistency for the Social 
Discomfort subscale in Samples 1 and 2 was α = 0.89 and α = 0.87, respectively.  
Brief Fear of Negative Evaluation Scale – 8 (BFNE-8; Carleton, Collimire, & 
Asmundson, 2007). The BFNE-8 is a unidimensional, 8-item revised version of the Brief 
Fear of Negative Evaluation scale (BFNE; Leary, 1983) that assesses fear of negative 
evaluation. Items are rated on a 5-point scale ranging from 1 (not at all characteristic of 
me) to 5 (entirely characteristic of me). Total scores range from 8 to 40, with higher 
scores indicating greater fear of negative evaluation. Sample items include, “I am afraid 
that other people will find fault with me,” and “When I am talking to someone, I worry 
what they may be thinking about me.” The BFNE-8 was found to reliable and valid in 
SSc using the SPIN population (Fox et al., in progress). In the present sample, the 
internal consistency for Samples 1 and 2 was α = 0.97 and α = 0.96, respectively. 
Social Appearance Anxiety Scale (SAAS; Hart, Flora, Palyo, Fresco, Holle, & 
Heimberg, 2008). The SAAS is a 16-item, unidimensional assessment of fear in 
situations where one’s appearance may be evaluated. Items are rated on a response scale 
ranging from 1 (not at all) to 5 (extremely). Total scores range from 16 to 80, with higher 
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scores indicating greater fear of situations where one’s appearance may be evaluated. The 
SAAS can be a predictor of poor body image controlling for social anxiety in the general 
population (Hart et al., 2008). Sample items include, “I am concerned people won’t like 
me because of the way I look,” and “I get nervous when talking to people because of the 
way I look.” A psychometric analysis of the measure in the SPIN cohort demonstrated 
that the unidimensional SAAS is an appropriate measure for use with SSc patients (Mills 
et al., 2015a). In the present sample, the internal consistency for Samples 1 and 2 was α = 
0.96 and α = 0.96, respectively. 
Social Interaction Anxiety Scale-6 (SIAS-6; Peters, Sunderland, Andrews, Rapee, 
& Mattick, 2012). The SIAS-6 is a unidimensional, six-item, short-form measure of 
anxiety resulting from social interactions developed from the 20-item SIAS (Mattick & 
Clarke, 1989). Response options range from 0 (not at all characteristic or true of me) to 4 
(extremely characteristic or true of me). There is a total score computed from summing 
all items, with higher scores indicating greater interactional anxiety. Sample items 
include, “I have difficulty making eye contact with others” and “I have difficulty talking 
with other people.” A psychometric analysis of the measure using the SPIN cohort 
demonstrated that the unidimensional SIAS-6 is an appropriate measure for use in both 
limited and diffuse SSc patients (Gholizadeh et al., 2015b). In the present sample, the 
internal consistency for Samples 1 and 2 was α = 0.89 and α = 0.88, respectively. 
Objective skin involvement. Objective skin involvement was assessed via the 
physician-reported modified Rodnan skin score (mRss; Clements et al., 1990). The mRss 
is a measure of skin thickening in 17 bodily areas assessed via palpitation and using a 
four-point scale (0 = uninvolved to 3 = severe thickening). Total scores range from 0 to 
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51, with higher scores reflecting greater thickening and disease involvement. The 
measure is widely used as an indicator of disease severity in SSc and frequently used as a 
primary outcome measure in clinical trials because of its reliability, validity, and 
responsiveness to change (Clements et al., 1995). The mRss can be analyzed as a single 
continuous variable in statistical analyses (Amjadi et al., 2009).  
Auxiliary psychosocial measures. Patient Health Questionnaire (PHQ-8; 
Kroenke, Spitzer, & William, 2001). The PHQ-8 is a well-validated self-report screener 
for depression. Patients endorse items on a 0 (Not at all) to 3 (Nearly every day) response 
scale. Scores 5, 10, 15, and 20 categorize mild, moderate, moderately severe, and severe 
depression respectively. The PHQ-8 rather than the PHQ-9 is recommended for use in 
SSc because the item assessing suicide has poor predictive validity for self-harm 
(Razykov Hudson, Baron, Thombs, & Canadian Scleroderma Research Group, 2013). 
The internal consistency for Samples 1 and 2 was α = 0.88. 
The Patient-Reported Outcomes Measurement Information System (PROMIS®)-
29; Cella et al., 2010).  PROMIS is a research initiative that develops and 
psychometrically evaluates item banks for a given construct so that a patient-reported 
outcomes measure can be developed. The PROMIS-29 is a multi-dimensional, 29-item 
self-report measure that uses items from the seven domains of physical function, anxiety, 
depression, fatigue, sleep disturbance, pain interference, and ability to perform social 
roles; four items from each domain are provided in addition to an 11-point rating scale 
for pain intensity (ranging from 0-10). Each item has response values ranging from 1 to 5 
(except pain intensity) and a raw score can be created for each domain ranging from 4 
(lowest possible score) to 20 (highest possible scores). Scores are often standardized 
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using a T score-metric set to 50 + 10 (mean + SD). Higher scores on the symptom-type 
domains (i.e., anxiety) indicate worse symptoms. The measure has been validated for use 
in SSc (Hinchcliff et al., 2011; Kwakkenbos et al., 2015b). Internal consistency for the 
PROMIS-29 in SSc has not been reported. Previously research has demonstrated that SSc 
patients scored 0.2 to 0.7 SD lower than the general population across domains except for 
the physical functioning domain, for which SSc patients scored 1 SD lower (Khanna et 
al., 2012). For the present analysis, the PROMIS-29 Anxiety domain was used, and the 
internal consistency for Samples 1 and 2 was α = 0.92. 
The Scleroderma Health Assessment Questionnaire (SHAQ; Steen & Medsger, 
1997) was developed from the Health Assessment Questionnaire (HAQ; Fries et al., 
1980). The SHAQ includes the eight domains of the HAQ disability index and scales for 
pain, patient global assessment, vascular, digital ulcers, lung involvement, and 
gastrointestinal involvement. The eight HAQ domains are scored from 0 (without 
difficulty) to 3 (unable to do); the maximum scores from each of the eight domains are 
added together and divided by the number of completed categories. The added SHAQ 
items are continuous VAS scales that are transformed into 0-3 scores. The measure has 
shown good reliability and validity in SSc (see Pope, 2011). For the present analysis, the 
SHAQ-Disability (SHAQ-DI) domain was used. The internal consistency for Samples 1 
and 2 was α = 0.95. 
3.4 Data Analytic Plan 
Data preparation. The data were examined and cleaned in order to remove 
participants as described in the methods. The total sample (N = 942) was then 
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randomized using SPSS Version 24.0 into two random samples: Sample 1 (N = 469) and 
Sample 2 (N = 473).  
Analysis for specific Aim 1. For the first aim, exploratory LPA was used to 
derive categorical latent variables that signified profiles of similarly scoring individuals 
using three subjective indicators of body image (i.e., the total score of the Body 
Concealment Scale for Scleroderma and the two subscales of the Brief Satisfaction with 
Appearance Scale [Dissatisfaction with Appearance and Social Discomfort]; three 
subjective indicators of social anxiety (total scores from the Brief Fear of Negative 
Evaluation Scale-8, the Social Appearance Anxiety Scale, and the Social Interaction 
Anxiety Scale-6); and one objective indicator of skin involvement (the mRss). In order to 
account for potential gender-specific body image differences (Thompson, 2004), the 
analysis was run both 1) with all participants, and 2) excluding male participants in order 
to examine if there was a change in group membership, as described in the exploratory 
analyses section. Gender was also used as an auxiliary variable for comparison of groups 
in Aim 2. LPA was conducted using MPlus, version 7.2 (Muthén & Muthén, 1998-2012).  
The LPA used all observations of the aforementioned body image and social 
anxiety constructs in order to identify classes via maximum likelihood estimation. It 
should be noted that moderate to high correlations among the measures were expected 
given that various aspects of body image are being assessed, and this does not impede the 
analysis. LPA was used to identify profiles of individuals scoring similarly on the 
continuous variables such that complex relationships among these constructs could be 
summarized in a meaningful and accessible way.   
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In LPA/LCA, the analysis commences with a model with one subgroup, adding 
more subgroups until optimal model fit is determined (Kongsted & Nielsen, 2016). The 
optimal number of classes was derived via evaluation of models per the Lo-Mendell-
Rubin Adjusted Likelihood Ratio Test (LMRT; Lo, Mendell, & Rubin, 2001), the 
Bootstrapped Likelihood Ratio Test (BLRT; Arminger, Stein, & Wittenberg, 1999; 
McLachlan & Peel, 2000), Akaike information criteria (AIC; Akaike, 1974, sample size-
adjusted Bayesian information criteria (sBIC; Schwarz, 1978), and Entropy 
(Ramaswamy, DeSarbo, Reibstein, & Robinson, 1993). The LMRT is a statistical test to 
determine whether there is a significant improvement in model fit comparing a model 
with k profiles to a model with k -1 profiles using a log-likelihood (rather than chi-
square) distribution (Lo et al., 2001); the test has been identified as a useful indicator in 
simulation studies (Nylund et al., 2007). The BLRT is also a likelihood-based technique 
that has performed well in simulation studies (Nylund et al., 2007).  
One challenge in mixture modeling is that there can be disagreement among the 
various indicators. There is not one, universally accepted indicator to determine the 
number of classes (Nylund et al., 2007). Thus, researchers must decide and prioritize 
among the various indicators to determine an optimal solution. The justification of 
classes is akin to the determination of the face validity of the identified solution and 
cannot be garnered from statistical tests; it is incumbent on the researcher to provide an 
explanation for why the groups are meaningful and appropriate (Kongsted & Nielsen, 
2016). As Jung and Wickrama (2008) argued, “…the number of classes depends on a 
combination of factors in addition to fit indices, including one’s research question, 
parsimony, theoretical justification, and interpretability. Keeping this in mind, fit indices 
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and tests of model fit should not be the final word in deciding on the number of classes. 
However, they are useful in the initial exploratory stages of analyses” (p.311). 
In the present study, the BLRT, LMRT, and entropy were first considered to 
compare the fit of the target model to a comparison model that has one fewer class; the p-
values derived from the BLRT and LMRT were examined to determine whether the 
solution with fewer or greater profiles had superior fit. A significant p-value (p < .05) 
would indicate that the solution with one more profile (i.e., k + 1) is superior whereas a 
non-significant p-value (p > .05) would indicate that the solution with one fewer profile 
(k) is appropriate. Entropy is an indicator that examines the uncertainty of classification 
to determine how accurate the classes are (Celux & Soromenho, 1996); values that are 
closer to one (i.e., larger) will indicate superior accuracy. Although there are no defined 
cut-offs, values that fall below 0.80 indicate poor separation between classes; higher 
values correspond to greater confidence that the individuals in a sample have been placed 
into the most accurate group given the number of classes being assessed (Ramaswamy et 
al., 1993). In cases where there is disagreement among BLRT, LMRT, and entropy, the 
researcher can turn to descriptive indices and interpretability. In cases where there is 
disagreement among the statistical indicators, the solution with fewer classes would be 
the more parsimonious solution. Researchers arguing for the merits of adding an 
additional class in such scenarios should consider the relative improvement of model fit 
indices and interpretability that would be achieved at the cost of parsimony (de Cock & 
Shevlin, 2014). The AIC and sBIC were also examined as descriptive fit indices such that 
smaller values suggested better fit. Furthermore, the number of patients in a given class 
was considered given that solutions with classes comprising less than 5% of the sample 
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size are often considered untenable (Hipp & Bauer, 2006). In addition to the statistical 
indicators of model fit, the interpretability and theoretical justification for the classes was 
considered, as described in Muthén (2006). Additionally, the replicability of the solution 
between the two samples was taken into consideration, such that priority was given to the 
solution that was most defensible in both samples 
There is no way to directly calculate power for LPA. However, if a sample is too 
small, this may produce unstable solutions (Roesch, Villodas, & Villodas, 2010) or limit 
the ability to identify small but clinically meaningful groups (Kongsted & Nielsen, 2016). 
Some researchers have argued that, as in structural equation modeling, sample sizes of 
200 are considered adequate for LPA (Schumacker & Lomax, 2004).  
Analysis for specific Aim 2. Following the identification of the best-fitting 
models, a three-step approach to examine relationships among the latent profile variables 
and auxiliary variables was used to evaluate potential differences in sociodemographic, 
medical, and psychosocial variables as a function of profile group membership as 
described in Asparouhov and Muthén (2014). This is an alternative to the more 
commonly used single-step mixture modeling approach, allowing the identification of 
predictors of the latent profiles using Mplus. This approach by Lanza et al. (2013), also 
described in Vermunt (2010), been shown to outperform one-step approaches 
(Asparouhov & Muthén 2014). Traditionally, after the number of classes has been 
determined, the latent classification is treated as an observed variable and individuals are 
assigned to the most likely profiles to estimate between-class differences on specified 
covariates. But, this approach no longer retains an important benefit of latent models, 
which is taking classification uncertainty into account (Lanza et al., 2013). The Lanza et 
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al. (2013) approach is an alternative to confront these shortcomings via a simultaneous 1) 
estimation as a latent variable, and 2) estimation of the difference between estimated 
classes on specified distal (i.e., independent/predictor) variables. Additionally, Lanza et 
al.’s (2013) approach is robust to violation of multinomial logistic regression assumptions 
(Asparouhov & Muthen, 2013).  
Thus, the distal variables are treated as latent class predictors simultaneously with 
the LPA estimation model in an auxiliary model (Perrig-Chiello, Hutchison, Morselli, 
2015). To summarize the three-step approach, in the first step, the latent profile model is 
estimated using the identified indicator variables. Next, a variable is created identifying 
the most likely profile for each participant using the latent profile distribution in step one. 
Finally, profile membership is regressed on the predictor or distal variables. In the 
analysis, the output includes all pairwise comparisons between the two specified classes 
akin to ANOVA using post-hoc comparisons, but using chi-square tests. Each of these 
analyses was run separately for Sample 1 and Sample 2.  
The Lanza et al. (2013) three-step method was used to empirically evaluate 
potential differences in sociodemographic, medical, and psychosocial variables as a 
function of profile group membership after the identification of patient typologies. 
Specifically, potential differences in sociodemographic (i.e., age, gender, race, education, 
income, marital status), medical/functioning (i.e., disease duration, disease subtype, 
disease severity, telangiectasias, skin pigmentation changes, fingertip scars, 
sclerodactyly, and lower hand thickening) and psychosocial (i.e., depression, SHAQ-
Disability domain, and PROMIS-29-Anxiety domain) variables were examined as a 
function of group membership.  
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Chapter 3 is being prepared in part for publication. This publication will be co-
authored by Vanessa L. Malcarne, Scott C. Roesch, Marie-Eve Carrier, Linda 
Kwakkenbos, Sarah D. Mills, Rina S. Fox, and Brett D. Thombs. The dissertation author 
was the primary investigator and author of this material.   
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CHAPTER 4: RESULTS 
4.1 Participant Characteristics and Preliminary Analysis 
The sample characteristics for the total sample, Sample 1, and Sample 2 can be 
found in Table 1. Interdependent t-tests revealed no significant differences across key 
study variables between Sample 1 and Sample 2. There were 469 and 473 participants in 
Samples 1 and 2, respectively, with sufficient data to be included in the LPA. The 
samples were predominantly female, White, married/common law status, and had 
attained at least some college education, with an average age of approximately 55 years 
old.  
4.2 Body Image Profiles 
Primary analysis: Sample 1. Models containing one, two, three, four, and five 
profiles were fit to the Sample 1 data. Table 2a presents the fit indices for each of the five 
models. Across the indicators of model fit, the two-profile solution outperformed the one-
profile solution. Comparing the three-profile solution to the two-profile solution, there 
was some disagreement with the model-fit indicators. Although the three-class solution 
had lower values for the AIC and sBIC, a higher value for entropy, and significant BLRT, 
the LMRT was not significant (p = 0.144). Examination of the four and five profile 
solutions indicated that the LMRT was again not significant. In undertaking a substantive 
evaluation of the profiles and examining the sample means and conditional response 
means, the addition of a profile did not change the pattern of scores; the pattern was 
consistently all lower or higher scores for the variables included in the LPA regardless of 
the number of profiles. In other words, a two-profile solution identified a high-low 
pattern, whereas a three-profile solution identified a high-medium-low pattern. Thus, 
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considering that the two-profile solution was arguably better fitting in the replication 
sample (see below), the two-profile solution was selected as a more parsimonious 
solution to describe the observed pattern. The sample means and conditional response 
means for the two-profile solution have been provided (see Table 3a and Figure 1). 
Profile 1 comprised 71.2% of the sample (n = 334) and included individuals with an 
average objective skin involvement score of 7.03 (SD = 9.6) and subjective body image 
and social anxiety scores lower than the overall sample mean across all included 
measures. Profile 1 was labeled the Appearance Comfortable group. Profile 2 comprised 
28.8% of the sample (n = 135), and included individuals with an average objective skin 
involvement score of 9.87 (SD = 10.6) and subjective body-image and society anxiety 
scores higher than the overall sample mean across all included measures. Profile 2 was 
labeled the Appearance Distressed group.  
The analysis was rerun with only the female participants in the sample, but the 
two-profile solution was still superior. Thus, the male participants were retained in the 
analysis.  
Primary analysis: Sample 2. Models containing one, two, three, four, and five 
profiles were also fit to the Sample 2 data. Table 2b presents the fit indices for each of the 
five models. Across the indicators of model fit, the two-profile solution outperformed the 
one-profile solution. Although the three-profile solution had lower AIC and sBIC values 
and a significant BLRT value as compared to the two-profile solution, the LMRT was not 
significant and the entropy was lower, suggesting that the two-profile solution was the 
better fit. Examining the four and five profile solutions, the LMRT was not significant 
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and the entropy values were lower than the two-profile solution. Thus, a two-profile 
solution was deemed the most appropriate statistical solution in Sample 2.  
A substantive analysis was also undertaken via an examination of the sample 
means and conditional response means (see Table 3b and Figure 2). Profile 1 comprised 
79.3% of the sample (n = 375) and included individuals with an average objective skin 
involvement score of 7.65 (SD = 8.8) and subjective body-image and social anxiety 
scores lower than the overall sample mean across all included measures. Profile 1 was 
labeled the Appearance Comfortable group. Profile 2 comprised 20.7% of the sample (n 
= 98), and included individuals with an average objective skin involvement score of 9.62 
(SD = 10.3) and subjective body-image and society anxiety scores higher than the overall 
sample mean across all included measures. Profile 2 was labeled the Appearance 
Distressed group.  
The analysis was rerun with only the female participants in the sample, but the 
two-profile solution was still superior. Thus, the male participants were retained in the 
analysis.  
Exploratory analyses. A number of exploratory analyses were also undertaken to 
examine 1) subjective body image and social anxiety profiles without the objective mRss 
measure; 2) subjective body image and social anxiety profiles without the objective mRss 
measure with only female participants; 3) all included indicators in the LPA in only 
female participants; 4) all included measures in the LPA with the addition of the 
psychosocial measures (i.e., the PHQ, HAQ, PROMIS-Anxiety); 5) all included measures 
in the LPA with the addition of the psychosocial measures (i.e., the PHQ, HAQ, 
PROMIS-Anxiety) in only female participants. Across these exploratory analyses, the 
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two-profile solution remained the most robust and parsimonious solution when taking 
both samples into consideration. The patterns in conditional response means remained 
similar. The model fit indices for these exploratory models are included in Appendix B.  
4.3 Associations of Appearance Groups with Sociodemographic, Medical, and 
Psychosocial Variables 
 Sociodemographic variables. For Sample 1 participants, significant associations 
were found between group membership and age (p < 0.001), gender (p < 0.001), and 
marital status (p = 0.003; see Table 4a). Specifically, participants in the Appearance 
Distressed group were significantly younger and more likely to be single and female. 
There were no significant relationships between group membership and race or 
education.  
 In Sample 2, a significant association was found between group membership and 
age (p < 0.001). Specifically, participants in Appearance Distressed group were 
significantly more likely to be younger. There were no significant relationships in Sample 
2 between group membership and gender, marital status, race, or education. 
 Medical variables. For participants in Sample 1, significant associations were 
found between group membership and disease subtype (p < 0.001); years since 1st non-
Raynaud’s symptom (p = 0.033); sclerodactyly (p = 0.017); lower hand thickening (p < 
0.001); fingertip scars (p = 0.001); and pigmentation (p = 0.029; see Table 4b). 
Specifically, participants in the Appearance Distressed group were significantly more 
likely to have diffuse disease, more years since first non-Raynaud’s symptom, lower hand 
thickening, fingertip scars, and pigmentation issues. There were no significant 
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relationships in Sample 1 between group membership and years since diagnosis, 
telangiectasia, or BMI.  
 For participants in Sample 2, significant associations were only found between 
group membership and disease subtype (p = 0.020) and pigmentation (p = 0.006; see 
Table 5b). Specifically, participants in the Appearance Distressed group were 
significantly more likely to have diffuse disease and pigmentation issues. There were no 
significant relationships in Sample 1 between group membership and years since first 
non-Raynaud’s symptom, years since diagnosis, sclerodactyly, lower hand thickening, 
fingertip scars, telangiectasia, or BMI. 
Psychosocial variables. For participants in Sample 1, significant relationships 
were found between group membership and all psychosocial measures (all ps < 0.001; 
see Table 4c). Specifically, participants in the Appearance Distressed group were 
significantly more likely to have higher PHQ-8 (i.e., depressive symptomatology) 
SHAQ-DI (i.e., disability), and PROMIS-Anxiety (i.e., anxious symptomatology) scores.  
For participants in Sample 2, significant relationships were also found between 
group membership and all psychosocial measures (all ps < 0.001; see Table 5c). 
Specifically, participants in the Appearance Distressed group were significantly more 
likely to have higher PHQ-8 (i.e., depressive symptomatology) scores, HAQ (i.e., 
disability), and PROMIS-Anxiety (i.e., anxious symptomatology) scores.  
Chapter 4 is being prepared in part for publication. This publication will be co-
authored by Vanessa L. Malcarne, Scott C. Roesch, Marie-Eve Carrier, Linda 
Kwakkenbos, Sarah D. Mills, Rina S. Fox, and Brett D. Thombs.. The dissertation author 
was the primary investigator and author of this material.
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CHAPTER 5: DISCUSSION 
The present study aimed to identify profiles of patients based on variables 
indicating objective physical changes and subjective body image and social anxiety in the 
context of SSc, a chronic illness with appearance impacts in socially relevant areas of the 
body. Once profiles were derived, the second aim was to compare profiles on key 
sociodemographic, medical, and psychosocial variables. 
As will be further explicated below, two profiles emerged after running various 
iterations of the LPA in both Samples 1 and 2. These two profiles were substantively 
analyzed for patterns of scores and termed the Appearance Comfortable (n = 334 and n = 
375 in Samples 1 and 2, respectively) and Appearance Distressed (n = 135 and n = 98 in 
Samples 1 and 2, respectively) groups. The Appearance Comfortable group was 
characterized by less skin involvement, less body concealment behaviors, less 
dissatisfaction with appearance, less social discomfort, less fear of negative evaluation, 
less social appearance anxiety, and less social interaction anxiety. The Appearance 
Distressed group was characterized by more skin involvement, more body concealment 
behaviors, more dissatisfaction with appearance, more social discomfort, more fear of 
negative evaluation, more social appearance anxiety, and more social interaction anxiety. 
In both samples, younger age, diffuse disease subtype, and the presence of hypo/hyper-
pigmentation were associated with membership in the Appearance Distressed group. 
Additionally, patients in the Appearance Distressed group had significantly higher scores 
on measures of depressive and anxious symptoms and physical disability.  
 
  50 
5.1 LPA-derived Groups of Objective Skin Involvement, Subjective Body Image, 
and Subjective Social Anxiety 
In the first aim, LPA was utilized to derive profiles of patients in order to 
optimize homogeneity within groups and heterogeneity between groups (Roesch et al., 
2010). It had been hypothesized that multiple (i.e., more than two) profiles would emerge 
differentiating multiple groups representing individuals with similar objective skin 
involvement scores but differing subjective dissatisfaction and social anxiety scores and 
multiple groups representing similar personal dissatisfaction scores but differing social 
anxiety scores. In the present analysis, the two-profile solution emerged as the most 
robust and parsimonious model in both samples. Furthermore, across the exploratory 
analyses that were conducted (see Appendix B), the two-profile solution remained the 
most defensible solution across the iterations of the analysis per the statistical, 
descriptive, and substantive interpretations. Examining the conditional response means 
for each variable can aid in the interpretation of the identified profiles. In addition, 
comparisons to outside groups, when such comparisons are available in the literature, can 
further help to characterize the profiles.   
In the present results, the Appearance Comfortable and Appearance Distressed 
groups differed on objective skin involvement using the mRss. The mRss score is often 
used as a proxy for disease severity in SSc (Czirjàk, Foeldvari, & Müller-Ladner, 2008). 
The score can also be considered a proxy for appearance because the mRss score broadly 
represents degree of skin thickening, which contributes to appearance changes. The 
Appearance Distressed groups in both samples had higher mRss scores, as well as poorer 
outcomes for all the other included personal and social indicators of body image 
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compared to the Appearance Comfortable group. This could indicate that the two groups 
are best characterized as simply differentiating a sicker group of patients with worse 
appearance changes and who are, not unexpectedly, more personally and socially 
distressed than a less sick group of patients with less severe appearance changes, and less 
concurrent personal and social distress.   
However, although the difference in objective skin scores, as measured by the 
mRss, was statistically significant, the difference was relatively small. Considering the 
methodology of the mRss and the range of possible scores, it would appear that the 
differences in the present sample are likely not substantial in terms of severity or 
visibility. To derive an mRss score, the clinician palpitates the skin in each of 17 body 
areas, including the face, upper arms, forearms, hands, fingers, chest, abdomen, thighs, 
forearms, and feet. A rating is given for each palpitated area per the following scoring 
criteria: 0 (No Involvement), 1 (Mild Involvement), 2 (Moderate Involvement), or 3 
(Severe Thickening; Clements et al., 1995), with scores ranging from 0-51. The mean 
differences between groups were 2.84 and 1.97 in Sample 1 and Sample 2, respectively. 
Specifically, the Appearance Comfortable group in both samples had only slightly lower 
mRss scores (M = 7.03, SD = 9.6 in Sample 1; M = 7.65, SD = 8.8 in Sample 2) 
compared to the Appearance Distressed group (M = 9.87, SD = 10.6 in Sample 1; M = 
9.62, SD = 10.3 in Sample 2). Comparing the median scores in the two samples, the 
similarities between groups become more evident. In Sample 1, the overall median was 
5.00, whereas the medians for the Appearance Comfortable and Appearance Distressed 
groups were 4.00 and 6.00, respectively. In Sample 2, the overall median was 5.00, and 
the medians for the Appearance Comfortable and Appearance Distressed groups were 
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also 5.00. Furthermore, an examination of the frequencies of scores by groups 
demonstrated relatively similar ranges. In Sample 1, the range of mRss scores in the 
Appearance Comfortable group was 0-47, with 8.1% (n = 27) of the sample having an 
mRss of 0 and 5.7% (n = 21) of the sample having an mRss of 20 or greater. The range of 
mRss scores in the Appearance Distressed group was 0-45, with 6.7% (n = 9) of the 
sample having an mRss of 0 and 10.4% (n = 17) of the sample having an mRss of 20 or 
greater. In Sample 2, the range of mRss scores in the Appearance Comfortable group was 
0-44, with 9.3% (n = 35) of the sample having an mRss of 0 and 8.3% (n = 38) of the 
sample having an mRss of 20 or greater; the range of mRss scores in the Appearance 
Distressed group was from 0-48, with 11.0% (n = 11) of the sample having an mRss of 0 
and 12.2% (n = 16) of the sample having an mRss of 20 or greater.  
Additionally, for both groups, the mean mRss scores and standard deviations were 
similar to scores in the literature for other non-SPIN SSc samples (e.g., M = 9.0, SD = 8.7 
in Jewett et al. [2012a] with a Canadian sample; M = 9.5, SD = 8.6 in Jewett et al. [2010] 
in a U.S. sample; M = 6.4, SD = 5.9 in Kwakkenbos et al. [2012] in a Dutch sample; M = 
8.70, SD = 8.5 in Mills et al. [2015] in a U.S. sample; M = 8.6, SD = 6.7 in Tedeschini et 
al. [2013] in an Italian sample). 
Some studies have examined what mRss score differences may be clinically 
important. In a double-blind, randomized clinical trial (RCT) with 134 SSc patients with 
diffuse disease that evaluated minimally important difference (MID) in mRss, scores 3.2 
to 5.3 (0.40–0.66 effect size; Khanna et al., 2006) were found to indicate MID. However, 
estimates of MID may depend on baseline scores (Crosby, Kolotkin, & Williams, 2003), 
and the Khanna et al. (2006) study substantiated this as individuals with higher baseline 
  53 
mRss scores required larger changes in the score to be considered minimally improved 
per physician report. The baseline mRss score in the aforementioned RCT was a mean of 
21 (SD: 8), and thus a clinically meaningful difference in scores may actually be smaller 
in the present sample. However, MID, as assessed in Khanna et al. (2006), was meant to 
indicate a change in scores for the purpose of clinical trial outcomes and was anchored by 
physician reports of global health. Study physicians were asked to rate the change in the 
patient’s health over two years and this was the anchor used to determine MID. 
Therefore, MID in this setting reflected a clinical change in health status and not 
necessarily any direct or meaningful change in appearance. Similarly, skin involvement 
severity has been described in terms of overall disease severity in clinical trials, but not in 
relation to appearance. In one clinical trial (Khanna et al., 2009), inclusion criteria 
included overall mRss scores > 20 or scores > 16 with truncal involvement. Thus, the 
region of skin involvement may also be used clinically to distinguish severity. Amjadi et 
al. (2009) noted this cutoff as indicating “moderately severe skin disease” (p. 2492), 
however justification was not provided. The Medsger criteria for SSc severity describes 
an mRss of 0 as normal, 1-14 as mild, 15-29 as moderate, 30-39 as severe, and > 40 as 
end stage disease (Medsger et al., 2003). Keeping in mind the variability present in both 
profiles, the mean mRss scores for both the Appearance Comfortable and Appearance 
Distressed groups would suggest mild disease per the Medsger criteria. Again, though, 
this is in relation to clinical outcomes in SSc generally and not appearance specifically.  
To date, there is no known MID in skin scores to determine an objective 
difference in appearance. Furthermore, few studies have assessed relationships among 
mRss and body image or psychosocial correlates of body image. Two studies examining 
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mRss as a correlate of depressive symptomatology did not find significant associations 
(Kwakkenbos et al., 2012; Tedeschini et al., 2013). In one of the few studies directly 
examining the role of skin involvement in appearance, mRss was not significantly 
associated with appearance self-esteem (van Lankveld et al., 2007). However, Jewett et 
al. (2012a) found significant correlations between mRss scores and the Brief-SWAP-DA 
and Brief-SWAP-SD scores (r = 0.24, p < 0.001 and r = 0.23, p < 0.001, respectively). In 
one other study with SSc patients that considered mRss in the context of an appearance 
variable, there was no significant difference comparing scores in patients identified as 
experiencing impacts of disfigurements versus those not (Tedeschini et al., 2013). Of 
note, a validated assessment was not used to evaluate appearance impacts in this study. A 
dichotomous variable was derived for impacts of disfigurement based on answers to the 
question, “Do the changes of your body image induced by disease negatively influence 
your behavior or relationships with other people?” (p. 189). Overall, in the limited 
research that exists, there is disagreement regarding the role of mRss in body image.  
How clinically meaningful the mRss differences between the two profiles 
identified in both samples really are in terms of appearance is an empirical question that 
remains yet to be answered. However, considering the above information, the differences 
in mRss do not seem substantially different. It is unlikely that there would be a marked 
appearance change corresponding to the mean differences identified. Therefore, it is of 
particular interest that, although the differences in objective skin involvement were 
arguably relatively small, the differences in body image and social anxiety scores were 
relatively large, suggesting that the experience of living with appearances changes in SSc 
is driven by factors beyond objective skin involvement.  
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Although the two identified groups were somewhat similar on the degree of 
objectively measured skin involvement, they were quite different on both body image and 
social anxiety indicators. Regarding body image, scores for the BCSS, Brief-SWAP-DA, 
and Brief-SWAP-SD were markedly higher for patients in the Appearance Distressed 
group. An examination of the BCSS sample and conditional response means (Table 3a 
and 3b), revealed much higher scores in the Appearance Distressed group (M = 16.81 in 
Sample 1; M = 16.19 in Sample 2) as compared to the Appearance Comfortable group (M 
= 4.52 in Sample 1; M = 4.82 in Sample 2). The BCSS items represent behavioral 
modifications (e.g., hiding hands, wearing concealing clothing, avoiding shaking hands) 
made in response to one’s appearance. There are no norms or cut-offs for the BCSS, but 
considering that responses for the nine items range from 0 (never) to 5 (always), with 
higher scores indicating more concealment behaviors, the Appearance Distressed group 
appears to either be engaging in some concealment behaviors a significant portion of the 
time (e.g., a patient with hand concerns may be endorsing a higher frequency of 
concealment behaviors for the four items referencing hands), or engaging in all of the 
behaviors at least some of the time. Contrastingly, the Appearance Comfortable group 
seems to be making very few concealment attempts, possibly engaging in only one 
scenario much of the time (e.g., wearing clothes that he/she does not like) or a few of the 
scenarios very occasionally. The behavioral responses to appearance changes seem to be 
quite different between the two groups such that the Appearance Comfortable does not 
seem to be making many changes at all, whereas the Appearance Distressed group is 
clearly engaging in concealment behaviors.  
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Similarly, in the present study, the Appearance Distressed group was more 
dissatisfied and socially uncomfortable via the Brief-SWAP-DA as compared not only to 
the Appearance Comfortable group but also to the overall sample means for Samples 1 
and 2 (see Tables 3a and 3b). An examination of the Brief-SWAP-DA (i.e., personal 
body image dissatisfaction) sample and conditional response means (Table 3a and 3b), 
revealed higher scores in the Appearance Distressed group (M = 12.64 in Sample 1; M = 
12.70 in Sample 2) as compared to the Appearance Comfortable group (M = 7.72 in 
Sample 1; M = 8.02 in Sample 2). The Appearance Distressed group also scored higher 
compared to a non-SPIN SSc sample assessed by Jewett et al. (2012) on the Brief-
SWAP-DA (M = 8.4, SD = 5.2); the mean reported in the Jewett et al. study was 
relatively close to the overall sample means for Samples 1 and 2 and the Appearance 
Comfortable group mean scores. The Brief-SWAP-DA measures self-reported 
dissatisfaction via three directly worded-items asking about dissatisfaction with one’s 
face, arms, and hands. The response options ranged from 0 (strongly disagree) to 6 
(strongly agree), with higher scores indicating greater dissatisfaction. Thus, it appears 
that a moderate level of dissatisfaction or at least ambivalence about one’s appearance (3 
was a response option for neutral) was present in the Appearance Distressed group. The 
Appearance Comfortable group, however, appears to be at least somewhat satisfied with 
their appearance. Considering that the Brief-SWAP-DA is capturing the evaluative 
dimension of the personal aspects of body image, what the difference in scores suggests 
is that although individuals in both groups are presenting with relatively mild skin 
involvement, the Appearance Distressed group is more personally dissatisfied with these 
mild bodily changes than the Appearance Comfortable group.  
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Turning to the Brief-SWAP-SD, scores for the Appearance Distressed group (M 
= 11.64 in Sample 1; M = 11.02 in Sample 2) were much higher than the Appearance 
Comfortable group (M = 2.82 in Sample 1; M = 3.32 in Sample 2). Similarly, the 
Appearance Distressed group also scored much higher compared to the same Jewett et al. 
(2012) SSc sample described above (M = 5.1, SD = 5.1); the mean that Jewett et al. 
(2012) reported was relatively close to the sample mean scores for Samples 1 and 2 but 
much higher than Appearance Comfortable mean scores. The Brief-SWAP-SD measures 
social discomfort via three items using the same response scale described above. The 
items reference discomfort in the presence of others, feeling unattractive to others, and 
feeling that to others would not want to touch the patient. Although there are no formal 
norms, the scores in the Appearance Distressed group indicate that individuals agree or at 
least somewhat agree that their condition makes them uncomfortable socially, while 
scores in the Appearance Comfortable group actually suggest little to no social 
discomfort.  
As with the body image scores, the social anxiety indicator scores (i.e., the 
BFNE-8, SAAS, and SIAS-6) also were much higher in the Appearance Distressed group 
as compared to the Appearance Comfortable group. Scores in the Appearance Distressed 
group were also higher than the sample means for Samples 1 and 2, and comparator 
samples, when available, from the literature. An examination of the BFNE-8 sample and 
conditional response means (Table 3a and 3b), revealed much higher scores in the 
Appearance Distressed group (M = 24.45 in Sample 1; M = 25.62 in Sample 2) as 
compared to the Appearance Comfortable group (M = 12.71 in Sample 1; M = 13.31 in 
Sample 2). Response options ranged from 1 (not at all characteristic of me) to 5 (entirely 
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characteristic of me) for the eight items that assessed fear of being negatively evaluated 
by social others, for example, worrying about what someone may be thinking about them 
when they are engaged in a conversation with that person. A different variant of the Fear 
of Negative Evaluation scale was used in a sample of 49 SSc patients (Richards, Herrick, 
Griffin, Gwilliam, & Fortune, 2004); in that study although the mean scores fell below 
the threshold for social anxiety, 27% of patients (n = 13) did have scores meeting the 
social anxiety cutoff. Unfortunately, there is no cutoff for social anxiety using the BFNE-
8 version of the measure that was used in the present study. However, in a sample of 
healthy college students (Coles, Pietrefesa, Schofield, & Cook, 2008), mean BFNE-8 
scores were 20.88 (SD = 8.01). Scores in the Appearance Distressed group were 
somewhat higher than this mean, indicating that individuals in this group felt that having 
fears of negative evaluation were more characteristic of them than did healthy college 
students. Interestingly, however, participants in the Appearance Comfortable group 
seemed to be doing markedly better in terms of fears of negative evaluation than the 
average college student.  
An examination of the SAAS sample and conditional response means (Table 3a 
and 3b) also revealed relatively much higher scores in the Appearance Distressed group 
(M = 43.25 in Sample 1; M = 49.0 in Sample 2) as compared to the Appearance 
Comfortable group (M = 21.83 in Sample 1; M = 22.70 in Sample 2). In studies with 
physically healthy college students, the mean scores were 30.23 (SD = 13.22) in a coed 
sample of 118 students (Levinson & Rodebaugh, 2011) and 35.64 (SD = 12.82) in an all-
female sample of 90 students (Titchener & Wong, 2014). The 16 SAAS items include a 
broad range of concerns, such as feeling nervous about having one’s picture taken and 
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worrying that others will judge them because of their appearance; response options 
ranged from 1 (not at all) to 5 (extremely). In the present sample, scores indicating social 
anxiety specifically related to one’s appearance were much higher for individuals in the 
Appearance Distressed group versus physically healthy college students. However, 
scores in the Appearance Comfortable group were notably lower compared to physically 
healthy college students, suggesting that, even in the presence of disfigurement, these 
individuals were less anxious about their appearance in social settings versus non-
disfigured college students.  
Finally, considering SIAS-6 sample and conditional response means (Table 3a 
and 3b), the results indicated higher scores in the Appearance Distressed group (M = 5.42 
in Sample 1; M = 6.47 in Sample 2) versus the Appearance Comfortable group (M = 1.02 
in Sample 1; M = 1.48 in Sample 2). The measure has not been used in SSc outside of the 
SPIN sample, so comparisons to other SSc populations cannot be made. Because the 
SIAS-6 was developed to assess social anxiety in medically healthy populations, the 
measure is often used in psychiatric settings (e.g., Peters et al., 2012) where the mean 
scores tend to be higher (e.g., M = 13.2, SD = 4.9 in a social anxiety sample). However, 
scores in a non-psychiatric, healthy community setting (Le Blanc et al., 2014) were 
markedly lower (M = 1.5, SD = 2.25). Considering that the response options for the six 
items ranges from 0 (not at all characteristic or true of me) to 4 (extremely characteristic 
or true of me), it seems that the Appearance Distressed group had more social interaction 
concerns versus non-disfigured controls, but fewer as compared to psychiatric 
population; the healthy community scores were comparable to those of the Appearance 
Comfortable group whereas the psychiatric sample scores were much higher. In a sample 
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of sexual minority adults (Puckett, Levitt, Horne, & Hayes-Skelton, 2015), the scores 
were more comparable to those in the Appearance Distressed group (M = 4.7, SD = 4.8) 
and higher than those in the Appearance Comfortable group. A cutoff score of 7 has been 
identified as identifying between social phobia patients and non-patients using the SIAS-
6 (Peters et al., 2012). Thus, the average patient in the Appearance Distressed group in 
the present samples can be conceptualized as nearing the clinical cutoff score for social 
phobia (renamed Social Anxiety Disorder in the American Psychiatric Associations 
Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition [DSM-V; APA, 
2013]). Specifically, in Sample 1, 33.3% (n = 45) of the Appearance Distressed and 2.1% 
(n = 7) of the Appearance Comfortable group met the cutoff for Social Anxiety Disorder. 
In Sample 2, 42.9% (n = 42) of the Appearance Distressed and 3.5% (n = 13) of the 
Appearance Comfortable group met the cutoff for Social Anxiety Disorder 
The two profiles had scores that were consistently higher or lower across all the 
indicators of body image and social anxiety, suggesting that the personal and social 
indicators relate more closely than hypothesized. The hypothesized pattern of finding 
groups differentiating patients scoring similarly high or low on personal distress but 
scoring differently on the social anxiety indicators was not identified. A more rigidly 
demarcated pattern differentiating two distinct group was found such that patients in the 
Appearance Comfortable group were coping well both personally and socially while 
patients in the Appearance Distressed group were struggling with the personal and social 
aspects of living with visible differences.  
In sum, the two identified profiles suggest that, even in a sample with relatively 
low skin involvement, there are some patients who have responded to their appearance 
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changes with minimal personal dissatisfaction and relatively low social anxiety, and 
others who seem quite distressed about their appearance on both personal and social 
levels. This interpretation should be made with the caveat that we do not know what true 
MID is for the mRss in terms of appearance. Regardless, two groups of patients who are 
coping with the personal and social aspects of appearance changes very differently were 
identified in the present analysis. The associations of the two identified groups with 
sociodemographic, medical, and psychosocial variables can further unpack the 
implications of group membership.  
5.2 Associations of LPA-derived Groups with Sociodemographic, Medical, and 
Psychosocial Variables 
 The second aim of the present study was to identify relationships of group 
membership to sociodemographic, medical, and psychosocial variables. In both samples, 
younger age, diffuse disease subtype, and the presence of hypo/hyper-pigmentation were 
associated with membership in the Appearance Distressed group. Additionally, patients 
in the Appearance Distressed group had significantly higher scores on measures of 
depressive and anxiety symptomatology and disability. The robust findings that existed 
for both samples will be discussed first, followed by a discussion of the differences 
between samples.  
Significant auxiliary variables in both samples. In both samples, patients in the 
Appearance Distressed group were somewhat younger, as described further below. In the 
present analysis, age was the only sociodemographic variable to significantly predict 
group membership in both Sample 1 and Sample 2. Across the variables included in 
research examining relationships with body image dissatisfaction in SSc, younger age has 
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been one of the most frequently reported variables associated with body image 
dissatisfaction (Amin et al., 2011; Benrud-Larson et al., 2003; Ennis et al., 2013; Jewett 
et al., 2012). In the broader disfigurement literature, younger age has been associated 
with poorer outcomes as well (Fauerbach et al., 1995 cited in Benrud-Larson et al., 
2003). Across previous research in disfigurement, younger individuals (i.e., pediatric 
populations) have been described as more appearance-focused with more demanding 
body image ideals that can contribute to greater challenges in coping with disfigurement 
(Benrud-Larson et al., 2003; Rumsey & Harcourt, 2004). Although the role of age in 
adjustment to disfigurement typically refers to the difference between adolescents/teens 
and older adults, there can be unique challenges to dealing with appearance changes for 
middle aged adults as well (Rumsey & Harcourt, 2004). The present sample was 
comprised only of adults, who had an overall mean age of around 55 years old. It is 
conceivable that because skin changes associated with aging (e.g., increased wrinkles, 
thinner and less elastic skin, pigmentation changes) are also occurring at around this age, 
some patients who are older and already experiencing changes in their appearance may 
be less distressed than younger patients who have not yet noticed major aging-related 
changes to their appearance. Patients in the Appearance Distressed group (M = 50.36 in 
Sample 1; M = 50.60) were significantly younger than patients in the Appearance 
Comfortable group (M = 58.01 in Sample 1; M = 55.90 in Sample 2), although the sample 
could generally be characterized as comprised of middle-aged women and men 
(consistent with the epidemiology of the SSc). Another factor to consider, however, is the 
age at onset of symptoms (including appearance changes). Although age at onset of 
appearance changes was not directly evaluated in the present study, this variable may also 
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be influencing the present results. Ennis et al. (2003) found that, while disease duration in 
SSc generally was not associated with poorer body image outcomes, younger age at onset 
of first non-Raynaud’s symptom was associated with body image dissatisfaction. This 
same type of relationship may hold true specifically for age at onset of first appearance 
change. There may be a developmental distinction in terms of appearance concerns and 
coping potential being captured for women who start to experience the changes to their 
appearance in their late 30s/early 40s versus their 50s, considering that the mean years 
since first non-Raynaud’s symptom was approximately 11.  
Regarding medical variables, the results demonstrated that, across both Sample 1 
and Sample 2, disease subtype and pigmentation were associated with group membership 
such that patients with diffuse disease and the presence of pigmentation problems (i.e., 
hypo/hyper-pigmentation) were more likely to be in the Appearance Distressed group. 
Regarding the distinction between limited and diffuse disease, it is important to consider 
that in limited disease, skin thickening is typically constrained to the hands, arms, and/or 
face, whereas in diffuse disease, the skin involvement is widespread, including the trunk 
(Gabrielli et al., 2009; Steen, Powell, & Medsger, 1988). Thus, although there is more 
widespread skin involvement in diffuse disease, the additional involved areas that limited 
disease patients do not experience are in less visible parts of the body (i.e., the trunk). It 
is possible that truncal involvement, while not socially relevant in day-to-day encounters 
with strangers or non-intimate acquaintances, may have social impacts in intimate 
relations, leading to greater associated distress. Moreover, previous research has also 
related diagnosis of diffuse (versus limited) disease to greater body image dissatisfaction 
(Benrud-Larson et al., 2003; Ennis et al., 2013; Heniberg et al., 2008; Nusbaum et al., 
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2016). The increased severity of illness associated with diffuse disease (e.g., more 
internal organ involvement) may also be contributing to a more negative embodiment 
experience contributing to the greater body image distress in diffuse patients.  
Regarding the role of specific aspects of appearance in body image outcomes, of 
the five specific appearance variables that were included in the analysis, only 
pigmentation problems were significantly associated with group membership in both 
samples. The other variables (i.e., sclerodactyly, lower hand thickening, fingertip scars, 
and telangiectasias) that were not associated with group membership in both samples will 
be discussed further below. The visibility or severity of the appearance variables may 
have influenced the results; the dichotomous appearance variables did not include 
information regarding severity of the variables. Pigmentation changes may be more 
noticeable and impact larger areas of the body than the other assessed variables. 
However, in the one other study examining pigmentation problems and body image, there 
was no significant relationship with dissatisfaction with appearance or social discomfort 
as assessed via the Brief-SWAP (Jewett et al., 2012a). One reason for the discrepancy 
between the Jewett et al. (2012a) study and the present study may be the outcome of 
interest. In the Jewett et al. (2012a) study, the Brief-SWAP was the outcome of interest. 
The latent variables in the present study, however, included both personal and social 
aspects of body image and captured a distress dimension beyond that which was captured 
in the Brief-SWAP alone.  
Regarding the psychosocial auxiliary variables, in both samples, the analysis 
demonstrated that group membership was significantly associated with scores on 
measures of depressive symptomatology, anxiety symptomatology, and disability. 
  65 
Specifically, patients in the Appearance Distressed group were more likely to have 
higher PHQ-8, PROMIS-Anxiety, and SHAQ-DI scores. Thus, as hypothesized, the 
group with more appearance-related distress had worse depression, anxiety, and disability 
outcomes.  
Several studies have demonstrated a moderate relationship between poorer body 
image scores and adverse mood outcomes (Benrud-Larson et al., 2003; Jewett et al., 
2010; Jewett et al., 2015; Kwakkenbos et al., 2012; Leite et al., 2013; Mills et al., 2015; 
Van Lankfelt et al., 2007) or increased disability (Benrud-Larson et al., 2003; Heinberg et 
al., 2007; Mills et al., 2015; Van Lankfelt et al., 2007). The association of group 
membership with poorer mood outcomes suggests that individuals in the Appearance 
Distressed group are experiencing general anxiety and depression symptoms in addition 
to appearance-related distress. Regarding the PHQ-8, considering that scores 5, 10, 15, 
and 20 categorize mild, moderate, moderately severe, and severe depression respectively, 
means scores for patients in the Appearance Distressed group were in the moderate 
range, whereas mean scores for patients in the Appearance Comfortable group were 
below even the mild range of depressive symptoms.  
The PROMIS-Anxiety measure is scored using T-score metric set to 50 + 10 (M + 
SD); while mean scores for the Appearance Comfortable were just slightly below the 
mean of 50, scores for the Appearance Distressed group were approximately one full 
standard deviation higher than the mean. Because the PROMIS T-score metric is normed 
around the general US population (Liu et al., 2010), individuals in the Appearance 
Distressed group are reporting anxiety one standard deviation more severe than the 
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average U.S. person, while individuals in the Appearance Comfortable group are about as 
anxious as the average U.S. person (Schalet, Cook, Choi, & Cella, 2014).  
Regarding disability, items on the SHAQ-DI is scored from 0 (without difficulty) 
to 3 (unable to do) and total scores are transformed to the same 0 to 3 range. Mean scores 
for the Appearance Distressed group were around 1, whereas means scores for the 
Appearance Comfortable group were around 0.6, indicating a difference in functioning 
although both groups are relatively low on disability. The embodied experience in SSc 
may be different for patients experiencing this slightly greater disability; there may be a 
greater feeling of detachment from or distrust of one’s body promoting greater distress. 
Previous research examining body esteem in individuals with physical disabilities 
showed that physical disability adversely impacted body esteem and that social feedback 
may be a mediator of body esteem for individuals living with physical disabilities 
(Taleporos & McCabe, 2001). The combination of experiencing appearance changes and 
physical disabilities may be compounding the body-related distress that patients 
experience. Additionally, some of the appearance changes, for example hand 
contractures, may directly relate to both increased disability and poorer social outcomes.  
Cash et al. (2004c) argued, “While discontent with some aspect of one’s 
appearance increases one’s risk for the experience of emotional distress and psychosocial 
impairment, dissatisfaction per se is not a sufficiently valid index of dysfunction or 
disorder” (p. 364). There has been a call for a clearer distinction between body image 
dissatisfaction, which is relative common in community samples, and body image 
distress or disturbance, which captures a more pathological level of negative evaluation 
that includes psychological impairment and functioning deficits (Cash et al., 2004c; 
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Thompson, Heinberg, Altabe, & Tantleff-Dunn, 1999). Without a direct measure of the 
specific construct of body image distress, disturbance, or dysmorphia, one could argue 
that the moniker “Appearance Distressed” for the more impacted profile in the LPA may 
be inappropriate. However, the strong relationships between group membership and 
higher depressive and anxious symptomatology suggest that the construct of body image 
distress is indeed being harnessed in the Appearance Distressed group. This is interesting 
because, traditionally, the construct of body image distress is conceptualized as cohering 
at the intersection of body image dissatisfaction and appearance investment (Cash, 
2002a). Body image disturbance or distress has been differentiated from the more 
evaluative construct body image dissatisfaction (Cash et al., 2004c) via the inclusion of 
the appearance investment variable. However, even without a direct assessment of 
appearance investment, the Appearance Distressed group is essentially tapping in to the 
body image distress construct and identifying individuals with elevated psychological 
distress via anxiety and depression symptomatology.  
Non-significant auxiliary variables in both samples. Regarding the 
sociodemographic variables, education was not associated with group membership in 
either group. No significant relationship between education and body image outcomes in 
SSc has been reported in previous research (Jewett et al., 2012a), and thus it had been 
hypothesized that education would not be associated with group membership in the 
present study. Because of the varied educational systems in the countries included in the 
SPIN study, education was a continuous variable describing years of education completed 
starting with elementary/primary school. The sample was relatively well-educated with a 
mean of around 15 years of education completed, which would correspond to an average 
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educational attainment of at least some college/university education. It is possible that a 
sample with greater educational variance and categorical distinctions between different 
levels of education would have produced different results.  
 Race was also not a significant predictor of group membership in either sample. 
In one previous study, African American race had been associated with higher rates of 
body image dissatisfaction as compared to Caucasian race (Nusbaum et al., 2016). There 
has been some research indicating that African Americans with SSc generally have 
poorer prognoses as compared to White Americans with SSc, even after adjusting for age 
at disease onset, disease duration, sex, disease subtype, SES, health insurance status, and 
various medical indicators; this has been hypothesized to suggest a unique disease 
phenotypic expression in African Americans (Gelber et al., 2013). As described in the 
study methods, the SPIN sample included different country-specific racial identifications  
(i.e., in Canada options were Aboriginal, White, Asian, Black, Latin American, Arab, and 
Other; in the U.S. options were Asian, American Indian/Alaska Native, White, Native 
Hawaiian/Other Pacific Island, More than one race, and Black or African American; in 
France, options were White, Asian, African, and Other) that were re-coded in the dataset 
into White/Caucasian, Black/African-American, and All Other. Although the Nusbaum et 
al. (2016) study used the same three racial categories in their all U.S. sample, they had a 
much higher percentage of Black patients (27% versus 5.8% in the present sample). Thus, 
the lack of variability in the present sample may have precluded significant results. It is 
also possible that a more nuanced categorization of the specific racial categories (e.g., 
Asian) would have introduced significant relations to group membership. Such analyses 
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can be undertaken if future SPIN recruitment produces higher numbers of participants 
from non-White ethnicities.  
Regarding medical variables, BMI and telangiectasias did not predict group 
membership in either sample. BMI had not been previously assessed as a predictor of 
body image outcomes in SSc. Although higher BMI can be an important predictor of 
body image outcomes in other populations (Schwartz & Brownell, 2004), the impacts of 
the SSc can cause both weight gain (e.g., as a result of medications) and weight loss (e.g., 
related to gastrointestinal complications). Patients may have challenges associated with 
weight changes in either direction, and thus the linear relationship of BMI to group 
membership may not accurately capture the distress associated with weight change. 
Future research may seek to examine weight in terms of being both underweight and 
overweight.  
Although the presence of telangiectasias (i.e., widened blood vessels that can 
appear as thread-like lines across the skin) has been associated with body image 
dissatisfaction in previous research (Ennis et al., 2013; Jewett et al., 2012a), there was no 
association with group membership in either sample. In the total sample and across both 
Appearance Distressed and Appearance Comfortable groups in both samples, the 
presence of telangiectasias was around 70%. Additionally, as with all the appearance 
symptoms, the severity of the symptom was not assessed. Moreover, this specific 
symptom is not limited to SSc, and can appear in healthy individuals as well. Thus, it is 
possible that the noticeability and stigma of this symptom is less acute than more unique 
symptoms, such as finger thickening.  
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Differences between groups on associations with auxiliary variables. Two 
sociodemographic variables, gender and marital status, were associated with group 
membership in Sample 1 but not Sample 2. Specifically, patients in the Appearance 
Distressed group in Sample 1 were more likely to be female and single. Regarding 
gender, the majority of the existing research examining body image in SSc has been 
conducted only with women, given that the disease has a much higher prevalence in 
women; when men have been included (e.g., Amin et al., 2011; Ennis et al., 2013; 
Heinberg et al., 2007), analyses have not been conducted to examine differences in body 
image dissatisfaction by gender. In non-disfigured samples, women tend to have poorer 
evaluative body image outcomes as well as greater body image investment compared to 
heterosexual men (e.g., Muth & Cash, 1997). However, Rumsey and Harcourt (2008) 
reported that the evidence on gender in body image outcomes in visibly disfigured 
populations is discordant, with some studies showing no gender differences in body 
image outcomes (e.g., White, 1982) and others finding poorer outcomes in females (e.g., 
Carr, Harris, & James, 2000).  
The association between marital status and body image dissatisfaction has been 
mixed in the literature, with one study finding a significant association between being 
single and body image dissatisfaction (Ennis et al., 2013) and one study finding no 
relationship (Jewett et al., 2012). Another study examining correlates of depression in 
SSc found that being single was associated with greater depressive symptomatology 
(Thombs, Hudson, Taillefer, Baron, & Canadian Scleroderma Research Group, 2008b). 
The majority of the overall present sample (around 73%) was married or common law 
status. In Sample 1 where marital status was significantly associated with group 
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membership, while around 77% of individuals in the Appearance Comfortable group 
were partnered, only 61.5% in the Appearance Distressed group were partnered. Given 
the cross-sectional nature of the study, however, it could be argued that the couples who 
are able to remain (or become) a romantic dyad following the interpersonal challenges 
associated with the diagnosis of an incurable, chronic illness in one partner are already a 
self-selected, more highly satisfied group, both in terms of body image and relationship 
quality. Claims as to the directionality of the relationship cannot be made, so it is unclear 
if being in a relationship promoted better body image and social anxiety outcomes, or if 
better body image and social anxiety outcomes promoted initiating or maintaining a 
romantic relationship.  
There were also a number of medical variables associated with group membership 
in Sample 1 but not Sample 2. In Sample 1, more years since first non-Raynaud’s 
symptom and the presence of several appearance variables in addition to pigmentation 
(i.e., sclerodactyly, lower hand thickening, and fingertip scars) were associated with 
membership in the Appearance Distressed group. Years since first non-Raynaud’s 
symptom is commonly used as a proxy for disease duration in SSc, given that the length 
of time to achieve an accurate diagnosis can be quite long for some patients. In SSc, the 
course of the changes in appearance tend to be such that the changes are rapid and 
progressive early in the course of the disease and then level out (Gholizadeh et al., 2017), 
so it was hypothesized that longer disease duration would not be associated with better 
appearance coping or more severe changes in appearance. Additionally, in previous 
research a significant association between years since first non-Raynaud’s symptom and 
body image dissatisfaction had not been identified (Ennis et al., 2013). In the present 
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sample, the mean duration since first non-Raynaud’s symptom was approximately 11 
years; the difference in means for the Appearance Dissatisfied and Appearance 
Comfortable was about two years (12.7 versus 10.8, respectively). Thus, individuals in 
the Appearance Dissatisfied group had been living with SSc symptoms, likely including 
appearance changes, for approximately two years longer than those in the Appearance 
Comfortable in Sample 1. While it may have been conjectured that greater time living 
with the changes would have enabled improved coping and adjustment to the visible 
differences, the longer disease duration was actually associated with greater 
dissatisfaction and distress in Sample 1. As described above relating to age, the longer 
disease duration may be associated with a younger age at onset of first appearance 
symptom, contributing to more distress. It is also possible that individuals who have lived 
longer with the appearance changes have experienced more negative social responses to 
their disfigurement. 
Given the significant associations of appearance variables with body image 
outcomes in the literature, it was somewhat surprising that all of the appearance variables 
were not associated with group membership in the present study. Sclerodactyly, lower 
hand thickening, and fingertip scars were only associated with membership in the 
Appearance Distressed group in Sample 1. In previous literature, face tightening, skin 
tightening above the elbows, skin tightening above the knees, finger restriction (Benrud-
Larson et al., 2003), facial involvement (Jewett et al., 2012a), skin thickening of the right 
hand and fingers (Malcarne et al., 1999), and telangiectasias (Ennis et al., 2013) have 
been identified as significant correlates of body image dissatisfaction. However, as 
previously described, the dichotomous assessment of the appearance variables as 
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present/not present, versus a more nuanced description that included severity of each 
symptom, may have precluded significant findings. Furthermore, the appearance 
variables were all physician-rated. In line with the results of the present study 
demonstrating that objective severity does not relate directly to body image distress, it 
may be that physician ratings of presence of a given appearance symptom would not 
necessarily correspond to patient perceptions of noticeability and severity of that 
symptom.  
5.3 Implications of the Present Results 
The primary implication of the present research is that the subjective personal and 
social experiences of appearance changes in SSc appear to be driven by factors beyond 
objective skin involvement; one cannot simply assume degree of distress based on level 
of skin involvement, or disease severity. In the present analysis, two groups were 
identified that were generally similar in terms of skin involvement scores, which were 
relatively low and indicated mild skin thickening, but for whom the experience of living 
with these appearance changes seemed markedly different.  
In addition to appearance dissatisfaction (i.e., the evaluative component of body 
image), body image behaviors and anxiety were also included in the LPA, arguably 
coalescing to form a body image distress latent variable. Patients in the Appearance 
Distressed group can be characterized as not only dissatisfied with their appearance, but 
as truly psychologically distressed. Thus, there exists a group of patients, many of whom 
have mild disease, or at least mild skin thickening, who may appear physically similar to 
or “as sick as” other patients, but who are struggling personally and socially with their 
appearance changes. These are the patients who are most in need of intervention, and 
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who are arguably most at risk of falling between the referral cracks because they may not 
look sick enough (or different enough from the patients who do seem to be coping well) 
to warrant further support.  
Based on the present findings, it seems that younger patients with diffuse disease 
and pigmentation changes are most acutely at risk for adverse appearance-related 
outcomes, personally and socially. Thus, these are the characteristics that may point to 
patients, even those with mild skin involvement, at elevated risk for appearance and 
general psychological distress. Although some of the mechanisms driving these 
relationships were hypothesized in the discussion, it will be interesting to further examine 
the ways in which age, diffuse disease, and pigmentation may be impacting distress in 
future research. For example, including measures on sexual functioning in future research 
can help examine whether the intimacy impacts of the additional truncal skin 
involvement that diffuse disease can experience is what is contributing to the additional 
body image distress in these patients. Longitudinal research can examine the impacts of 
age throughout the disease course, potentially identifying critical developmental periods 
where the onset or worsening of appearances changes are more distressing (e.g., for 
younger patients who experience their first appearance-related symptom in their 30s, who 
do not yet perceive themselves as having experienced significant aging-related 
appearance impacts, versus patients who start to experience appearance changes later in 
life). Because the specific relationship with pigmentation changes was novel, future 
qualitative research can examine in what ways the experience of living with visible 
differences in SSc may be unique for patients with pigmentation changes, and why this 
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specific symptom may be more negatively impactful for patients than other appearance 
variables (e.g., telangiectasias).  
There are also clinical implications of the present study. Gholizadeh et al. (2017) 
suggested that clinicians foster a more open dialogue around body image concerns by 
simply asking all patients specifically about appearance-related concerns rather than 
attempting to elicit distress via a general screening tool or based on the patient’s 
appearance. While mRss or other indicators of severity (e.g., the physician’s own 
assessment of a given patient’s facial or hand severity) may be more accessible to 
physicians, the present results suggest that these factors will not adequately capture the 
patient experience of living with appearance changes. Moreover, even for patients with 
relatively mild skin thickening, there can be some patients who seem to cope well and 
others who seem to be truly distressed. Of course, this introduces a greater challenge to 
clinicians because the present findings suggest that identifying the patients who are truly 
suffering is complicated by the fact that these patients may not appear objectively more 
disfigured. However, the present study indicates that younger patients with diffuse 
disease who have experienced pigmentation changes may be most acutely at risk. The 
present results can normalize such concerns by underscoring that research has shown that 
body image concerns and social difficulties are common in SSc and related to many 
factors beyond objective skin thickening. This may open the door for distressed patients 
with relatively less severe disease to feel more validated in broaching topics related to 
body image and social anxiety.  
Unfortunately, clinicians may feel ill-equipped to handle such discussions.  
Another option for patients is support groups. In-person support groups do exist in many 
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cities around the world for SSc. These are typically peer-led groups that are established 
through patient advocacy organizations. A recent study examined the reasons for non-
participation among SSc patients (N = 242) in these groups, given that they can be an 
excellent form of psychosocial support (Gumuchian et al., 2017). Reasons for non-
participation could be distilled into personal reasons (e.g., not feeling comfortable in a 
group setting), practical reasons (e.g., no access to local groups), and beliefs about 
support groups (e.g., beliefs that support groups would be negative settings). A specific 
practical reason for non-attendance, that 8.7% of the sample endorsed, was discomfort 
with appearance. Thus, patients who are appearance distressed, who stand to benefit 
greatly from support, may be avoiding support group-based settings specifically because 
of their appearance.  
 Other resources beyond physicians and support groups are needed to help 
patients struggling with challenges related to appearance changes. One such resource is 
represented by an online intervention currently in development to specifically address 
body image concerns in SSc that is extremely relevant to the present sample and could be 
a useful referral. The SPIN body image intervention is a web-based intervention being 
developed to address the personal and social challenges of appearances changes in SSc 
(Kwakkenbos et al., 2013). The online format of the intervention may make the 
intervention more appealing and relevant to younger patients, who may be at greater risk 
for body image distress. The web-based format will also increase accessibility for 
patients with physical disabilities and more advanced (i.e., diffuse) disease that may 
prohibit in-person support seeking. Given the prevalence of social anxiety, the online 
intervention may also capture a highly anxious subset of patients who otherwise would 
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avoid in-person or group-based psychosocial interventions. Although there are certain 
factors that a psychosocial intervention cannot remedy (e.g., skin thickening), it is the 
subjective personal and social aspects of body image that appear to be driving elevated 
body image distress in the present study. These are direct targets of the SPIN 
intervention, which is grounded in both cognitive-behavioral skills (e.g., challenging 
unrealistic social concerns) and acceptance-based approaches (e.g., coping with the fact 
that one’s face looks different than it used to). Additionally, the intervention will include 
an optional module on camouflage/makeup that can address specific pigmentation 
concerns. The intervention is currently being developed and will undergo efficacy testing 
via a randomized controlled trial, but the findings of the present study suggest that the 
SPIN body image intervention will be an extremely relevant and useful tool for patients 
with a wide range of appearance changes in SSc. 
A third implication involves possible positive coping mechanisms associated with 
the Appearance Comfortable group.  Across all measures included in the LPA, the 
Appearance Comfortable group tended to score more favorably as compared not only to 
the overall sample means but also to other comparison groups, often including healthy 
community controls, suggesting that for some individuals, appearance changes may be 
introducing a heightened coping mechanism or resiliency. Grounded in Lazarus and 
Folkman’s (1984) Model of Stress and Coping, there is a rich literature examining the 
ways that the evaluation of a stressor (i.e., cognitive appraisal) and cognitive and 
behavioral attempts at managing a stressor (i.e., coping styles) can impact adjustment and 
outcomes related to chronic illness (e.g. Folkman, 2013; Sirois & Gick, 2014; Stanon & 
Snider, 1993). For example, the presence of emotion-focused coping (e.g., wishful 
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thinking, self-blame) has been related to worse psychosocial adjustment and increased 
depression, even after controlling for physician-rated illness severity (Bombardier, 
D’Amico, & Jordan, 1990). That patients who overall have mild skin thickening are 
experiencing the appearance impacts of a disease so differently suggests that differences 
in appraisals of the physical changes and coping styles related to the visible differences 
may be influencing outcomes.  
There could also be a meaning-making phenomenon taking wherein some 
individuals who have been faced with the stressors of SSc have been able to reorient their 
worldviews (including, perhaps, values placed on appearance). Park (2010) described 
meaning making as comprised of the following tenets: 1) individuals possess a cognitive 
capacity to orient and find global meaning in response to new experiences; 2) individuals 
appraise and ascribe meaning to experiences that possess the potential to challenge or 
place stress upon previously arrived upon global meaning; 3) the discordance between 
appraised meaning and global meaning is associated with distress; 4) this distress 
motivates meaning making; 5) this meaning making process has the underlying goal of 
reducing the discordance such that the world can again be a meaningful place in which 
the individual life has purpose; and 6) when the process is successful (i.e., the meaning 
made is achieved via meaning making), individuals are more highly adjusted and cope 
better.  
The diagnosis of the incurable disease SSc and the onset of unpredictable, 
uncontrollable, and undesirable appearance changes would certainly constitute the type of 
experience for which the meaning-making model may be applied (Park & Folkman, 
1997). Patients who have to face the unavoidable reality of appearance changes may find 
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themselves shifting values about appearance or reframing self-views and identity beliefs 
such that a changed appearance is no longer a barrier to (and, perhaps, even an impetus 
toward) living a meaningful life. There has been some criticism of the meaning-making 
framework, however. Some researchers have argued that better adjustment is not a 
process of meaning making, but rather the natural course of resiliency in humans; 
meaning making may actually promote maladaptive ruminative processes rather than 
recovery (Bonnano, Papa, Lalande, Zhang, & Noll, 2005).  
Rumsey and Harcourt (2004) also described that although the research in 
disfigurement tends to focus on poorer outcomes, there is some evidence for strengths 
and resilience rather than deficits associated with disfigurement. For example, in a study 
examining coping patterns in adults with cleft lip and palate, there was a high variability 
in outcomes, with a smaller subset of patients reporting positive outcomes associated 
with having a congenital visible difference (Cochrane & Slade, 1999). Regardless of 
whether it is conceptualized as resilience or meaning making, there appears to be a 
phenomenon taking place such that for some (the majority, in fact) individuals with SSc, 
the experience of living with a visible difference may promote better social anxiety 
outcomes compared to other SSc patients and perhaps, as evidenced by comparisons with 
general community samples, even compared to the general, non-disfigured public. This is 
a finding that warrants further research both of a qualitative nature, such that the 
underlying processes can be explored, and also via quantitative longitudinal designs that 
promote the tracking of personal and social adjustment to changes in appearance.   
5.4 Limitations 
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It is important to interpret the present results with relevant limitations in mind. 
The first limitation concerns the model selection process and is present in every LPA 
analysis. Because there are no gold-standard fit criteria, it is left to the researcher to select 
the number of classes based on a combination of fit criteria (e.g., entropy, likelihood ratio 
statistical tests; Tein, Coxe, & Cham, 2013). For the present analysis, LMRT, BLRT, and 
entropy were first considered, with the descriptive fit indices and substantive 
interpretation taken into consideration secondarily. Replicability between the two 
samples was also considered. Using the aforementioned criteria, the two-class solution 
emerged as the optimal solution. It is possible that focusing on other selection criteria 
could have changed the results. However, even considering that there was some 
disagreement across the indicators, the selection of a three (or greater)-profile solution 
would still not have supported the study hypothesis. An examination of the conditional 
response means revealed that for the groups that would have emerged, scores would have 
remained consistently higher or lower for all indicators in any additional groups. In other 
words, the difference would have been between a high-medium-low pattern versus a 
high-low pattern; the additional profiles in the three, four, or five solutions would not 
have introduced groups like the ones hypothesized, with some relatively higher and some 
relatively lower indicator values.  
Additionally, the SPIN Cohort is a convenience sample of SSc patients who are 
receiving treatment at SPIN recruiting centers, which tend to be large, university-based 
hospitals or centers with rheumatologists with expertise in SSc. Patients at these centers 
may differ from SSc patients in other settings. SPIN Cohort patients also complete all 
study questionnaires online, potentially further limiting the generalizability of findings. 
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Of note, however, patients who did not have access to the Internet or a means to complete 
the questionnaires but wanted to participate were provided access at the recruitment 
centers. Additionally, the majority of the present sample was White; given that aspects of 
body image may be socio-culturally bound (Fallon, 1990), results may not be 
generalizable to the body image experiences of participants from other racial/ethnic 
backgrounds, and the ability to make racial/ethnic group comparisons was limited. The 
cross-sectional nature of the study also precludes claims of causality or directionality. For 
example, it is not possible to know whether the Appearance Distressed patients were a 
more psychosocially distressed group prior to the SSc diagnosis. 
Another important limitation of the present research involves the conceptual 
underpinnings of body image as a construct. Body image is a multidimensional construct 
(Cash & Pruzinsky, 1990). Researchers have many options of specific dimensions of 
body image and related measures to utilize in order to capture a particular aspect of the 
construct (Thompson, 2011). An LPA (and most exploratory research) is only as good the 
measures that are included in the analysis; the groups are developed based on the selected 
indicators. It is conceivable that for each of the selected dimensions of body image, 
different measures could have been selected or entirely different dimensions of body 
image may have been targeted, potentially leading to different groups.  
5.5 Summary and Conclusions 
The results of the present study, even interpreted within the context of the 
aforementioned limitations, contribute to the growing literature on body image in SSc. 
The present study was the first to use LPA in the context of body image in SSc, and the 
first study to identify typologies of patients based on indicators of body image in any 
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disfiguring condition. The present study proposed to examine the role of various body 
image and social anxiety indicators in SSc. The results demonstrated that LPA can be 
used to distinguish between profiles of patients based on body image and social anxiety 
indicators. However, rather than a more complex, multi-group solution demonstrating 
variability in patients’ relationships with objective and subjective body image evaluations 
and personal and social aspects of body image, two distinct profiles were identified. The 
profiles distinguished between an Appearance Comfortable group, comprised of patients 
with lower objective skin involvement, better body image, and lower social anxiety and 
an Appearance Distressed group including patients who had higher objective skin 
involvement, poorer body image, and higher social anxiety. The results also elucidated 
variables that were associated with group membership and may be used to help identify 
patients who may be in need of intervention and who are at risk for poorer outcomes due 
to significant problems with personal and social facets of body image. Younger patients 
with diffuse disease and pigmentation changes seem to be particularly at risk for adverse 
appearance-related outcomes. 
An important implication of the present study is that the subjective experience of 
appearance changes in SSc appears to be driven by factors beyond objective skin 
involvement, and thus one cannot simply assume degree of distress based on level of skin 
thickening. Although this can make the identification of patients at risk for distress more 
challenging, it can also normalize and validate personal and social challenges of living 
with appearance changes even in patients with relatively mild disease. An SSc-specific 
body image intervention currently in development of the SPIN team that will target 
personal and social aspects of body image may be especially relevant for the Appearance 
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Distressed patients. Of interest, the subjective body image and social anxiety scores for 
the Appearance Comfortable group suggested that patients in this group not only fared 
better than their Appearance Distressed peers, but also had better outcomes than general, 
healthy community samples, possibly pointing to a meaning-making or resilience 
process. 
Chapter 5 is being prepared in part for publication. This publication will be co-
authored by Vanessa L. Malcarne, Scott C. Roesch, Marie-Eve Carrier, Linda 
Kwakkenbos, Sarah D. Mills, Rina S. Fox, and Brett D. Thombs.. The dissertation author 
was the primary investigator and author of this material. 
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FIGURES 
 
 
 
Figure 1. Standardized conditional response means for objective body image, subjective 
body image, and subjective appearance-related social anxiety variables in Sample 1 
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Figure 2. Standardized conditional response means for objective body image, subjective 
body image, and subjective appearance-related social anxiety variables in Sample 2 
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Table 1. Study characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. an (%); bM (SD);cYears of education completed starting with elementary/primary 
school; dmRss: modified Rodnan skin score 
Variable Total  
(N = 942) 
Sample 1  
(N = 469) 
Sample 2 
(N = 473) 
Sociodemographic variables  
Gendera    
    Female 823 (87.4) 415 (88.5) 405 (86.3) 
    Male 119 (12.6) 54 (11.5) 65 (13.7) 
Ethnicitya    
White 751 (79.8) 380 (81.0) 371 (78.4) 
 Black 55 (5.8) 28 (6.0) 27 (5.7) 
          Other 135 (14.3) 60 (12.8) 75 (15.9) 
 Missing 1 (0.1) 1 (0.2) 0 (0.0) 
Educationb,c 15.14 (3.34) 15.17 (3.6) 15.11 (3.4) 
Marital statusa    
Married/Common Law 687 (72.9) 339 (72.3) 348 (73.6) 
Not married 255 (27.1) 130 (27.7) 125 (26.4) 
Single 109 (11.6) 60 (12.8) 49 (10.4) 
Separated/Divorced 109 (11.6) 50 (10.7) 59 (12.5) 
Widowed 37 (3.9) 20 (4.3) 17 (3.6) 
Ageb 55.30 (12.4) 55.81 (12.9) 54.79 (11.8) 
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Table 1: Continued    
Variable Total Sample 
(N = 942) 
Group 1  
(N = 469) 
Group 2 
(N = 473) 
Medical variables  
Years since first non-Raynaud’s  
symptomb 
 
11.15 (8.5) 
 
11.39 (8.5) 
 
10.92 (8.4) 
Disease Subtype    
Limited 558 (59.2) 276 (58.8) 282 (59.6) 
Diffuse  384 (40.8) 193 (41.2) 191 (40.4) 
mRssd 7.97 (8.4) 7.86 (8.1) 8.07 (8.7) 
Telangiectasia    
     No 269 (28.6) 138 (29.4) 131 (27.7) 
     Yes 661 (70.2) 327 (69.7) 334 (70.6) 
     Missing 12 (1.3) 4 (0.9) 8 (1.7) 
Pigmentation    
     No 613 (65.1) 312 (66.5) 301 (63.6) 
     Yes 277 (29.4) 134 (28.6) 143 (30.2) 
     Missing 52 (5.5) 23 (4.9) 29 (6.1) 
Scleroderma    
     No 430 (45.6) 220 (46.9) 210 (44.4) 
     Yes 510 (54.1) 248 (52.9) 262 (55.4) 
    Missing  2 (0.2) 1 (0.2) 1 (0.2) 
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Note. an (%); bM (SD); BCSS: Body Concealment Score; BFNE-8: Brief Fear of Negative 
Evaluation Scale-8; Brief SWAP-DA: Brief Satisfaction with Appearance Scale- Social 
Discomfort Subscale; Brief-SWAP –SD: Brief Satisfaction with Appearance Scale-Social 
Discomfort Subscale; SIAS-6: Social Interaction Anxiety Scale-6: SAAS: Social 
Appearance Anxiety Scale; PHQ-8: Patient Health Questionnaire-8; SHAQ-DI: 
Scleroderma Health Assessment Questionnaire-Disability Index.
  
Table 1: Continued    
Variable Total Sample 
(N = 942) 
Group 1  
(N = 469) 
Group 2 
(N = 473) 
Sclerodactly  
     No 141 (15.0) 
     Yes 798 (84.7) 
    Missing  3 (0.3) 
Psychosocial variables  
BCSSb 7.68 (8.5) 8.10 (8.8) 7.25 (8.1) 
BFNE-8b 16.04 (8.1) 16.14 (8.4) 15.9 (7.8) 
Brief-SWAP-DAb 9.09 (5.2) 9.16 (5.2) 9.02 (5.07) 
Brief-SWAP-SDb 5.18 (5.1) 5.40 (5.3) 4.97 (5.0) 
SIAS-6b 2.43 (3.8) 2.30 (3.7) 2.55 (3.9) 
SAASb 28.20 (13.2) 28.08 (13.3) 28.22 (13.1) 
PHQ-8b 5.89 (5.2) 5.71 (5.1) 6.07 (5.2) 
SHAQ-DIb 0.74 (0.7) 0.74 (0.7) 0.72 (0.7) 
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Table 2a. Model fit indices for the 1-, 2-, 3-,  4- & 5-profile -profile solutions for Sample 
1 
 
Note. AIC: Akaike Information Criterion; sBIC: Sample-size adjusted Bayesian 
Information Criterion; BLRT: Bootstrapped Likelihood Ratio Test. 
 
Solution AIC sBIC Lo-Mendell 
Rubin Adjusted  
p-value 
Parametric 
bootstrapped 
LRT  p-value 
Entropy 
1 profile 22099.844 22113.520 --- ---- --- 
2 profile 21095.964 21117.453 0.0002 < .001 0.904 
3 profile 20771.658 20800.962 0.1443 < .001 0.922 
4 profile 20631.304 20668.422 0.5930 < .001 0.920 
5 profile 20487.035 20531.968 0.0826 < .001 0.929 
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Table 2b. Model fit indices for the 1-, 2-, 3-,  4- & 5-profile -profile solutions for Sample 
2  
 
Note. AIC: Akaike Information Criterion; sBIC: Sample-size adjusted Bayesian 
Information Criterion; BLRT: Bootstrapped Likelihood Ratio Test. 
 
 
  
Solution AIC sBIC Lo-Mendell 
Rubin 
Adjusted  
p-value 
Parametric 
bootstrapped LRT  
p-value 
Entropy 
1 profile 22172.886 22186.680 --- ---- --- 
2 profile 21187.959 21209.635 < .001 < .001 0.936 
3 profile 20873.273 20902.831 0.0027 < .001 0.883 
4 profile 20769.414 20806.854 0.1946 < .001 0.908 
5 profile 20676.350 20721.672 0.4276 < .001 0.905 
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Table 3a. Sample means and group conditional response means for Sample 1 
 
 M (SE) 
 Full sample 
(N = 469) 
Appearance 
Comfortable 
(n = 334) 
Appearance 
Distressed 
(n =135) 
Subjective Body  
Image Measures 
BCSS 8.104 (0.404) 4.518 (0.462) 16.806 
(1.178) 
Brief SWAP-
DA 
9.159 (0.241) 7.721 (0.374) 12.636 
(0.356) 
Brief SWAP-
SD 
5.397 (0.245) 2.823 (0.407) 11.640 
(0.433) 
Social Anxiety 
BFNE-8 16.139 (0.385) 12.712 (0.410) 24.452 
(1.275) 
SAAS 28.079 (0.612) 21.825 (0.545) 43.250 
(2.222) 
SIAS-6 2.305 (0.170) 1.021 (0.110) 5.419 (0.691) 
Objective Skin Involvement 
mRss 7.861 (0.376) 7.032 (0.524) 9.872 (0.909) 
 
Note. SE: standard error. 
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Table 3b. Sample means and group conditional response means for Sample 2 
 
 M (SE) 
 Full sample 
(N = 473) 
Appearance 
Comfortable  
(n = 375) 
Appearance 
Distressed 
(n =98) 
Subjective Body  
Image Measures 
BCSS 7.254 (0.373) 4.819 (0.357) 16.192 (1.309) 
Brief 
SWAP-DA 
9.019 (0.233) 8.016 (0.295) 12.701 (0.447) 
Brief 
SWAP-SD 
4.966 (0.228) 3.319 (0.293) 11.015 (0.436) 
Social Anxiety 
BFNE-8 15.945 (0.359) 13.309 (0.339) 25.624 (1.161) 
SAAS 28.328 (0.604) 22.703 (0.483) 48.981 (2.066) 
SIAS-6 2.545 (0.181) 1.477 (0.151) 6.468 (0.753) 
Objective Skin Involvement 
mRss 8.072 (0.398) 7.651 (0.454) 9.617 (1.041) 
 
Note. SE: standard error.  
  111 
Table 4a. Differences in sociodemographic characteristics among groups for Sample 1 
 
 
Note. aM (SD); bn (%);cYears of education completed starting with elementary/primary 
school. 
 
 
 
 
 
Variable Appearance 
Comfortable 
(n = 334) 
Appearance 
Distressed 
(n =135) 
Statistics  
   Overall Model 
𝜒2(1) 
p 
Agea 58.01 (12.08) 50.36 (13.36) 33.49 < 0.001 
Genderb   16.875 < 0.001 
     Female 285 (85.2) 130(96.3)   
     Male 49 (14.8) 5 (3.7)   
Marital Statusb 256 (76.8) 83 (61.5) 8.660 0.003 
Raceb     
   White 269 (80.6) 112 (82.7) 0.274 0.872 
   Black 20 (6.0) 8 (5.9)   
   Other 45 (13.4) 15 (11.4)   
Educationa,c 14.98 (5.15) 15.74 (5.25) 0.204 0.652 
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Table 4b. Differences in medical characteristics among groups for Sample 1 
 
 
Note. aM (SD); bn (%) 
 
  
Variable Appearance 
Comfortable 
(n = 334) 
Appearance 
Distressed 
(n =135) 
Statistics  
   Overall 
Model 𝜒2(1) 
 
p 
Disease Subtypeb   19.500 <0.001 
     Limited 221 (66.3) 56 (41.3)   
     Diffuse 113 (33.7) 79 (58.7)   
Years Since 1st 
 Non-Raynaud’sa 
10.79 (8.13) 12.74 (9.26) 4.553 0.033 
Years Since 
Diagnosisa 
9.35 (7.68) 11.01 (9.04) 3.519 0.061 
Lower Hand 
Thickeningb 
274 (82.4) 122 (90.7) 5.074 0.017 
Sclerodermab 153 (46.0) 94 (69.7) 21.30 <0.001 
Fingertip Scarsb 117 (35.2) 72 (53.7) 11.96 0.001 
Telangiectasiasb 235 (70.4) 94.5 (70.0) 0.007 0.931 
Pigmentationb 86 (25.8) 45 (35.2) 7.079 0.029 
BMIa 25.90 (6.31) 25.66 (6.07) 0.077 0.781 
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Table 4c. Differences in psychosocial characteristics among groups for Sample 1 
 
 
Note. aM (SD); bn (%) 
 
  
Variable Appearance 
Comfortable 
(n = 334) 
Appearance 
Distressed 
(n =135) 
Statistics  
   Overall 
Model 𝜒2(1) 
 
p 
PHQ-8a 3.89 (3.45) 10.17 (5.69) 143.18 <0.001 
SHAQ-DIa 0.60 (0.60) 1.08 (0.71) 47.64 <0.001 
PROMIS-Anxietya 47.76 (8.30) 59.15 (8.21) 183.96 <0.001 
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Table 5a. Differences in sociodemographic characteristics among groups for Sample 2 
 
 
 
Note. aM (SD); bn (%);cYears of education completed starting with elementary/primary 
school 
 
  
Variable Appearance 
Comfortable 
(n = 375) 
Appearance 
Distressed 
(n =98) 
Statistics  
   Overall 
Model 𝜒2(1) 
 
p 
Agea 55.90 (11.4) 50.69 (12.4) 14.167 <0.001 
Genderb   1.848 0.174 
     Female 319 (85.2) 88 (90.2)   
     Male 55 (14.8) 10 (9.80)   
Marital Statusb 283 (75.4) 66 (67.0) 2.255 0.133 
Raceb   3.776 0.151 
   White 303 (80.5) 69.48 (70.9)   
   Black 21 (5.6) 6 (5.9)   
   Other 51 (13.9) 23 (23.2)   
Educationa,c 15.06 (5.15) 15.43 (5.25) 0.244 0.652 
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Table 5b. Differences in medical characteristics among groups for Sample 2 
 
 
Note. aM (SD); bn (%) 
 
Variable Appearance 
Comfortable 
(n = 375) 
Appearance 
Distressed 
(n =98) 
Statistics  
   Overall 
Model 𝜒2(1) 
 
p 
Disease Subtypeb   5.734 0.020 
   Limited 237 (63.1) 46 (46.9)   
   Diffuse 138 (36.9) 52 (53.1)   
Years Since 1st 
Non-Raynaud’sa 
10.97 (8.8) 10.75 (8.4) 0.054 0.817 
Years Since 
Diagnosisa 
9.26 (8.0) 9.33 (7.9) 0.005 0.945 
Sclerodactylyb 322 (86.1) 79 (81.7) 0.949 0.330 
Lower hand 
thickeningb 
202 (53.8) 60 (61.7) 1.713 0.191 
Fingertip Scarsb 152 (40.3) 47 (46.5) 1.029 0.310 
Telangiectasiasb 27 (73.3) 65 (66.6) 1.542 0.214 
Pigmentationb 107 (28.6) 44 (45.0) 7.534 0.006 
BMIa 25.72 (5.8) 26.18 (6.0) 0.484 0.487 
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Table 5c. Differences in psychosocial characteristics among groups for Sample 2 
 
 
Note. aM (SD); bn (%) 
 
  
Variable Appearance 
Comfortable 
(n = 375) 
Appearance 
Distressed 
(n =98) 
Statistics  
   Overall 
Model 𝜒2(1) 
 
p 
PHQ 4.47 (4.0) 10.82 (5.4) 119.24 <.001 
SHAQ-DI 0.64 (0.6) 1.04 (0.6) 28.12 <.001 
PROMIS-
Anxiety 
48.15 (8.4) 60.36 (7.4) 201.558 <.001 
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APPENDICES 
Appendix A. SPIN cohort description 
SPIN utilizes a novel research design called the cohort multiple RCT (cmRCT) 
design (Kwakkenbos et al., 2013). The design, a type of pragmatic trial design, was first 
described by Relton and colleagues (2010) as a response to some of the criticisms (e.g., 
limited external validity) of “gold standard” randomized controlled trials. The key 
characteristics of the cmRCT are described below:  
I. Recruitment of participants with condition of interest by way of a large, 
observational cohort  
II. The whole cohort participates in regular outcome measurement  
III. The design allows for multiple randomized controls trials for the duration 
nof the study period  
a. All eligible patients are identified from the entire cohort (e.g., 
patients who screen positive for depression) 
b. A random selection of the eligible patients is selected for 
intervention and their scores are compared to those eligible but not 
selected (i.e., receiving usual care)  
Kwakkenbos and colleagues (2013) noted that cmRCT is especially well-suited for rare 
diseases, such as scleroderma, in that it allows researchers to utilize participants from the 
same patient cohort for multiple trials (each with its own inclusion and exclusion criteria) 
and the consent process more closely mirrors actual clinical rather than research settings. 
Specifically, patients are informed in in the initial consenting that there are a number of 
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trials for which they may be eligible as part of the cohort, and they they will only be 
notified for trials where they have been offered the intervention, although their data may 
be used for comparative purposes. Kwakkenbos et al. (2013) described that, “In real-life 
healthcare situations, patients are only told of treatments that their healthcare provider 
can provide with certainty, and they are not told that the treatment they receive will be 
decided by chance.” (p. 4). 
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Appendix B 
Exploratory Analysis 1 Including Only Subjective Indicators  
 
Table 6a. Model fit indices for the 1-, 2-, 3-,  4- & 5-profile -profile solutions for Sample 
11 
 
Note. 1 Variables included: BCSS, Brief-SWAP-DA, Brief-SWAP-SD, BFNE-8, SAAS, 
SIAS-6  AIC: Akaike Information Criterion; 2sBIC: Sample-size adjusted Bayesian 
Information Criterion; BLRT: Bootstrapped Likelihood Ratio Test 
 
Solution2 AIC sBIC Lo-
Mendell 
Rubin 
Adjusted  
p-value 
Parametric 
bootstrapped 
LRT  p-
value 
Entropy 
1 profile 18798.118 18809.839 --- ---- --- 
2 profile 17801.696 17820.255  0.0005 < .001 0.904 
3 profile 17483.636 17509.033 0.1612 < .001 0.920 
4 profile 17392.722 17424.956 0.2724 < .001 0.898 
5 profile 17207.903 17246.976 0.0897 < .001 0.923 
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Table 6b. Model fit indices for the 1-, 2-, 3-,  4- & 5-profile -profile solutions for Sample 
21 
 
Note. 1 Variables included: BCSS, Brief-SWAP-DA, Brief-SWAP-SD, BFNE-8, SAAS, 
SIAS-6  AIC: Akaike Information Criterion; 2sBIC: Sample-size adjusted Bayesian 
Information Criterion; BLRT: Bootstrapped Likelihood Ratio Test. 
 
  
Solution2 AIC sBIC Lo-Mendell 
Rubin 
Adjusted  p-
value 
Parametric 
bootstrapped 
LRT  p-value 
Entropy 
1 profile 18783.991 18795.814 --- ---- --- 
2 profile 17800.747 17819.467 < .001 < .001 0.938 
3 profile 17487.092 17512.709 0.0035 < .001 0.884 
4 profile 17385.241 17417.755 0.4700 < .001 0.903 
5 profile 17295.027 7334.438 0.5786 < .001 0.895 
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Exploratory Analysis 2 Including Only Subjective Indicators and Only Females 
 
 
Table 7a. Model fit indices for the 1-, 2-, 3-,  4- & 5-profile -profile solutions for Sample 
11 
 
Note. 1 Variables included: BCSS, Brief-SWAP-DA, Brief-SWAP-SD, BFNE-8, SAAS, 
SIAS-6  AIC: Akaike Information Criterion; 2sBIC: Sample-size adjusted Bayesian 
Information Criterion; BLRT: Bootstrapped Likelihood Ratio Test. 
Solution2 AIC sBIC Lo-Mendell 
Rubin 
Adjusted  
p-value 
Parametric 
bootstrapped 
LRT  p-
value 
Entropy 
1 profile 16697.908 16708.168 --- ---- --- 
2 profile 15843.601 15859.846   0.0018 < .001 0.896 
3 profile 15558.488 15580.719 0.1820 < .001 0.922 
4 profile 15445.500 15473.716 0.0599 < .001  0.925 
5 profile 15309.643 15343.844 0.1155 < .001 0.924 
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Table 7b. Model fit indices for the 1-, 2-, 3-,  4- & 5-profile -profile solutions for Sample 
21 
 
Note. 1 Variables included: BCSS, Brief-SWAP-DA, Brief-SWAP-SD, BFNE-8, SAAS, 
SIAS-6  AIC: Akaike Information Criterion; 2sBIC: Sample-size adjusted Bayesian 
Information Criterion; BLRT: Bootstrapped Likelihood Ratio Test. 
 
  
Solution2 AIC sBIC Lo-
Mendell 
Rubin 
Adjusted  
p-value 
Parametric 
bootstrappe
d LRT  p-
value 
Entropy 
1 profile 16228.601 16238.658 --- ---- --- 
2 profile 15402.092 15418.016 < .001 < .001 0.935 
3 profile 15115.449 15137.240 0.0119 < .001 0.884 
4 profile 15002.439 15030.096 0.3589 < .001 0.905 
5 profile 14933.527 4967.051   0.4107 < .001 0.882 
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Exploratory Analysis 3 Including All Indicators and Only Females  
 
Table 8a. Model fit indices for the 1-, 2-, 3-, 4- & 5-profile solutions for Sample 11 
 
Note. 1 Variables included: mRss, BCSS, Brief-SWAP-DA, Brief-SWAP-SD, BFNE-8, 
SAAS, SIAS-6  AIC: Akaike Information Criterion; 2sBIC: Sample-size adjusted 
Bayesian Information Criterion; BLRT: Bootstrapped Likelihood Ratio Test. 
 
Solution2 AIC sBIC Lo-Mendell 
Rubin 
Adjusted  p-
value 
Parametric 
bootstrappe
d LRT  p-
value 
Entropy 
1 profile 19632.323 19644.293 --- ---- --- 
2 profile 18768.654 18787.464 0.0002 < .001 0.899 
3 profile 18476.396 18502.047 0.0851 < .001 0.924 
4 profile 18350.699 18383.190 0.0164 < .001 0.935 
5 profile 18216.732 18256.063 0.1592 < .001 0.929 
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Table 8b. Model fit indices for the 1-, 2-, 3-,  4- & 5-profile -profile solutions for  
Sample 21 
 
Note. 1 Variables included: mRss, BCSS, Brief-SWAP-DA, Brief-SWAP-SD, BFNE-8, 
SAAS, SIAS-6  AIC: Akaike Information Criterion; 2sBIC: Sample-size adjusted 
Bayesian Information Criterion; BLRT: Bootstrapped Likelihood Ratio Test. 
 
  
Solution2 AIC sBIC Lo-
Mendell 
Rubin 
Adjusted  
p-value 
Parametric 
bootstrapped 
LRT ‘ p-
value 
Entropy 
1 profile 19122.777 19134.511 --- ---- --- 
2 profile 18294.388 18312.826 < .001 < .001 0.932 
3 profile 18003.323 18028.467 0.0129 < .001 0.884 
4 profile 17891.867 17923.715 0.3631 < .001 0.904 
5 profile 17824.281 17862.833 0.4658 < .001 0.903 
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Exploratory Analysis 4 Including All Indicators + Psychosocial Indicators  
 
Table 9a. Model fit indices for the 1-, 2-, 3-,  4- & 5-profile -profile solutions for Sample 
21 
 
Note. 1 Variables included: mRss, BCSS, Brief-SWAP-DA, Brief-SWAP-SD, BFNE-8, 
SAAS, SIAS-6, PHQ-8, PROMIS-Anxiety, SHAQ-Disability; 2 AIC: Akaike Information 
Criterion; 2sBIC: Sample-size adjusted Bayesian Information Criterion; BLRT: 
Bootstrapped Likelihood Ratio Test. 
Solution2 AIC sBIC Lo-
Mendell 
Rubin 
Adjusted  
p-value 
Parametric 
bootstrapped 
LRT  p-
value 
Entropy 
1 profile 25928.244 25945.826 --- ---- --- 
2 profile 24721.019 24748.369 < .001 < .001 0.914 
3 profile 24355.597 24392.716 0.0341 < .001 0.928 
4 profile 24175.470 24222.356 0.0425 < .001 0.943 
5 profile 24073.941 24130.595 0.2134 < .001 0.942 
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Table 9b. Model fit indices for the 1-, 2-, 3-,  4- & 5-profile -profile solutions for Sample 
21 
 
Note. 1 Variables included: mRss, BCSS, Brief-SWAP-DA, Brief-SWAP-SD, BFNE-8, 
SAAS, SIAS-6, PHQ-8, PROMIS-Anxiety, SHAQ-Disability; 2 AIC: Akaike Information 
Criterion; 2sBIC: Sample-size adjusted Bayesian Information Criterion; BLRT: 
Bootstrapped Likelihood Ratio Test. 
  
Solution2 AIC sBIC Lo-
Mendell 
Rubin 
Adjusted  
p-value 
Parametric 
bootstrapped 
LRT  p-
value 
Entropy 
1 profile 26031.621 26049.356 --- ---- --- 
2 profile 24879.907 24907.494 < .001 < .001 0.920 
3 profile 24487.382 24524.822 0.0167 < .001 0.888 
4 profile 24366.275 24413.568 0.1027 < .001 0.902 
5 profile 24230.532 24287.677 0.1605 < .001 0.942 
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Exploratory Analysis 5 Including All Indicators + Psychosocial Indicators + Only 
Females 
 
Table 10a. Model fit indices for the 1-, 2-, 3-,  4- & 5-profile -profile solutions for 
Sample 11 
 
Note. 1 Variables included: mRss, BCSS, Brief-SWAP-DA, Brief-SWAP-SD, BFNE-8, 
SAAS, SIAS-6, PHQ-8, PROMIS-Anxiety, SHAQ-Disability; 2 AIC: Akaike Information 
Criterion; 2sBIC: Sample-size adjusted Bayesian Information Criterion; BLRT: 
Bootstrapped Likelihood Ratio Test. 
  
Solution2 AIC sBIC Lo-
Mendell 
Rubin 
Adjusted  
p-value 
Parametric 
bootstrapped 
LRT  p-
value 
Entropy 
1 profile 23050.387 23065.778 --- ---- --- 
2 profile 22012.892 22036.833 0.0013 < .001 0.906 
3 profile 21682.204 21714.695 0.0924 < .001 0.931 
4 profile 21510.028 21551.069  0.5601 < .001 0.935 
5 profile 21412.086 21461.678 0.0901 < .001 0.943 
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Table 10b. Model fit indices for the 1-, 2-, 3-,  4- & 5-profile -profile solutions for 
Sample 21 
 
Note. 1 Variables included: mRss, BCSS, Brief-SWAP-DA, Brief-SWAP-SD, BFNE-8, 
SAAS, SIAS-6, PHQ-8, PROMIS-Anxiety, SHAQ-Disability; 2 AIC: Akaike Information 
Criterion; 2sBIC: Sample-size adjusted Bayesian Information Criterion; BLRT: 
Bootstrapped Likelihood Ratio Test. 
 
 
 
 
 
  
 
Solution2 AIC sBIC Lo-
Mendell 
Rubin 
Adjusted  
p-value 
Parametric 
bootstrapped 
LRT  p-
value 
Entropy 
1 profile 22454.725 22469.810 --- ---- --- 
2 profile 21461.068 21484.535 < .001 < .001 0.912 
3 profile 21118.898 21150.745 0.0786 < .001 0.886 
4 profile 20978.835 21019.064 0.2380 < .001 0.910 
5 profile 20887.473 20936.083 0.2422 < .001 0.911 
